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Human milk (mother’s own milk and pasteurised donor human milk) is the food-of-
choice of all infants, especially those born sick and/or prematurely. Premature infants might 
have to rely on nasogastric tube feeding of expressed and stored human milk rather than being 
fed directly on the breast before their suckling reflux matures. There has been increasing 
concern regarding whether the integrity of human milk is preserved after all the necessary 
storage, handling and processing steps involved in pasteurizing and delivering the milk to 
infants. Human milk fats are particularly of a concern as more than half of the energy of 
human milk is derived from milk fats. The endogenous lipases of human milk could 
breakdown the main fat type triglycerides (TG) and release free fatty acids (FFA), under 
various conditions. The main goal of the thesis was to develop micro-sampling based dried 
milk spot (DMS) methods to measure the fat composition of human milk.  
Compared to the conventional liquid milk analysis, collecting human milk as DMS 
reduces the volume required for analysis, requires only ambient temperature storage and 
transportation, and simplifies the analytical procedures. I first adapted the established dried 
blood technique for profiling the total fatty acid composition of human milk, using 200 milk 
samples of mothers from three different countries. The strong correlation and tight variation 
between human milk samples analysed using the conventional method and the DMS method 
gave me the confidence to move forward with DMS technique.  
The major challenges involved in the process was to develop a DMS method for 
measuring FFA concentration of human milk, due to the instability of milk fats and the 
difficulty in separating FFA from TG. I tested several strategies and was able to reduce the 
contamination from TG to a very low level of 2%, which however was unacceptable as this 
could result in a falsely inflate the reading of FFA. I then discovered that milk fats collected 
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as DMS are susceptible to lipolysis due to breast milk lipases. Various attempts were made to 
inactivate the lipases. The final working system involved collecting human milk on silica gel 
impregnated paper, followed by microwaving to denature lipases. Milk fats can then be eluted 
and analysed by gas chromatography using an acid modified column that specifically detects 
FFA even in the presence of other fats (e.g. TG). The level of FFA measured by the DMS and 
conventional thin layer chromatography method were highly correlated (r=0.983, P<0.0001). 
To test the applicability and sensitivity of my DMS method, I then analysed 256 human milk 
samples collected in neonatal nursery at Women’s and Children’s Hospital, from a cohort of 
32 mothers who delivered mostly preterm infants.  
In conclusion, this thesis is the first report of a DMS technique for reliably measuring 
the FFA concentration of human milk. This DMS technique can be adapted by human milk 
banks for monitoring the quality of milk fats throughout processing procedures, it also has the 
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Chapter 1 Introduction  
 
I have conducted a comprehensive systematic review in the specific subject area which is 
included in the second chapter of the thesis. This chapter serves as a brief introduction to the 
overall concept, highlighting the gaps in the knowledge and the overall structure of the thesis.  
There is no published work related to Chapter 1.  
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Human milk is often referred as ‘liquid gold’ by health professionals, care givers and 
researchers working in the field of neonatal nutrition. The major components of human milk 
include a range of macronutrients (e.g. fats, proteins, and carbohydrates) and micronutrients 
(e.g. vitamins and minerals) providing essential nutritional support for normal growth and 
development. Despite being an optimal source of essential nutrients, human milk also 
contains unique non-nutritive bioactive components that have anti-infective, anti-
inflammatory, and immunomodulating roles that are beneficial for infants’ health [Andreas et 
al. 2015; Ballard & Morrow 2013; Nolan et al. 2019]. In addition, human milk contains 
important digestive enzymes that assist the digestion and absorption of nutrients, which are 
particularly valuable for infants born with compromised gastrointestinal functions [Ballard & 
Morrow 2013]. 
Human milk is the optimal food for all infants but is especially critical for infants born 
prematurely (<37 weeks’ gestation) who are at increased risk of poor outcomes due to their 
immaturity. Globally, more than 15 million infants are born preterm each year, and the 
incidence of preterm birth in Australia is 8.6% [Australian Government Department of Health 
2019], with a global incidence estimated at between 5% and 18% [World Health Organisation 
2018]. Many of these infants grow up with premature birth related complications (e.g. 
cerebral palsy, hearing, vision, and dental problems) and require ongoing medical support. In 
these preterm infants, human milk reduces infant mortality [Abram et al. 2014] and has a 
protective effect against a number of neonatal morbidities including necrotizing enterocolitis 
(NEC) [Corpeleijn et al. 2012; Lucas & Cole 1990; Meinzen-Derr et al. 2009; Miller et al. 
2018; Quigley et al. 2019], sepsis [Corpeleijn et al. 2012; Furman et al. 2003; Petal et al. 
2013] and retinopathy of prematurity [Bharwani et al. 2016; Okamoto et al. 2007]. 
Despite the known benefits of human milk for premature infants, these infants cannot be 
fed directly by breast due to the immaturity. This occurs as these infants have a range of 
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feeding difficulties associated with their immaturity, including the inability to suckle from the 
breast due to underdeveloped suck, swallow, and breathe coordination [Lau et al. 2007; 
Mizuno & Ueda 2003], which only matures between 32 and 34 weeks’ gestation [Delaney & 
Arvedson 2008]. As a result, these preterm infants have to be fed with expressed breast milk 
(EBM), either mother’s own milk or pasteurised donor human milk (PDHM) if mothers’ own 
milk is not available, via nasogastric tube feeding, before they can be fed on breast safely and 
adequately.  
Expressing and collecting milk subjects requires various storage and handling 
conditions before delivering it to the infants, and the process is further complicated if infants 
were to receive PDHM. This may include several rounds of storage (home, in the unit, during 
transportation and distribution), pasteurisation and repeated freezing and thawing, along with 
the addition of human milk fortifier (HMF), which is usually of bovine origin. These 
necessary steps for delivering EBM to infants may induce changes to the composition of milk, 
due to the possibilities of bacterial contaminations and the presence of enzymes that may 
breakdown the nutrients to smaller molecules during the process.  
Human milk fat is especially of a concern as it represents more than 50% of total energy 
of human milk, and provides the essential fatty acids (e.g. linoleic acid and linolenic acid) as 
well as long chain polyunsaturated fatty acids (e.g. arachidonic acid and docosahexaenoic 
acid). It is critical to ensure that the fat content and its composition is maintained to safeguard 
the normal growth and development of the infant. Lipids of human milk are either esterified 
(fatty acids bond to another structural component for energy storage) or non-esterified (fatty 
acids that are not bound to a certain structure and remain circulating freely). The majority 
(>98%) of the lipids in breast milk exist as esterified lipid in the form of triglyceride (TG), 
with the remainder made up of other esterified lipids including phospholipids (PL) and 
cholesterol esters (CE) and non-esterified free fatty acids (FFA). These different lipids are 
Chapter 1                                                       Introduction  
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also collectively referred as ‘lipid classes’. Lipolysis of human milk TG can occur during 
storage and handlings due to the presence of endogenous lipases (bile-salt stimulated lipase 
and lipoprotein lipase) that are naturally present in breast milk [Olivecrona & Hernell 1976; 
Lindquist & Hernell 2010], which would yield FFA and mono- or diglycerides. 
There are several ways to report the lipid content of human milk. Total fat is an 
expression of the total quantity of fat per volume of breast milk. Each lipid class in total fat 
can be quantified individually following certain separation techniques based on their 
polarities. The fatty acids attached to each of the structural lipids can be pooled together and 
expressed as total fatty acid composition. The fatty acid composition of milk is largely 
determined by maternal dietary intake [Innis 2014], whereas the changes to the proportion of 
lipid classes is a result of lipase activities and could potentially reflect how well the breast 
milk has been stored and handled [Bitman et al. 1983].  
In order to gain a full picture of how lipids of human milk are affected by different 
storage and handling process, I have conducted a systematic review that is included in 
Chapter 2 of the thesis. There have been several reviews in this field of research [Peila et al. 
2016; Peters et al. 2016], which only focused on the effect of a single handling procedure and 
often only examined its effect on total fat content and/or its fatty acid composition, but not the 
lipid classes of breast milk, which are considered sensitive parameters reflecting critical 
changes to human milk fats. Therefore, my review encompassed all possible conditions that 
EBM may be exposed to such as handling EBM at home, in neonatal nursey as well is in a 
human milk bank, to understand the collective effects of all different procedures on the fat 
composition (including total fat, fatty acid composition and lipid classes) of human milk.  
Measuring changes to the lipid profile of human milk requires accurate methods. Liquid 
milk is often used in most of the studies conducted in this field, but cold-chain storage and 
transportation is a burden for research cost and may introduce changes to the lipid of human 
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milk. The majority of the research also reported the use of a relatively large amount of human 
milk for measurement, ranging between 200𝜇L and 10ml, depending on the techniques 
applied. However, large volumes of breast milk for research purpose are often unavailable, 
especially when conducting research on preterm populations or collecting colostrum, where 
the mothers often experience difficulties with establishing feed or have low supply.  
Hence, being able to conduct research using smaller volumes of breast milk collected as 
dried spot would be beneficial for both researchers and participants in terms of collecting 
multiple samples without compromising infants’ need. Therefore the emphasis of my thesis 
was to develop a dried milk spot (DMS) method for measuring the lipid of human milk, 
which is covered in Chapter 3, 4 and 5. Although the overarching aim was to develop a 
DMS method, slight differences in focus occurred in each chapter. In Chapter 3 I focus on 
adapted an established method for profiling the total fatty acid composition of human milk for 
use in a DMS system, the tested its applicability in a clinical trial. While in Chapters 4 and 5 I 
focus on developing a DMS method specifically for the quantifying the amount of FFA 
present in human milk. During the development process, I attempted many different methods, 
often without success, but detailed experimental planning and discussion have been recorded 
in Chapter 4. The final successful method is described in Chapter 5 and the clinical study 
conducted using this method is covered in Chapter 6.  
To understand the magnitude of changes seen after storage and handling process, I first 
had to determine the baseline level of FFA in human milk (Chapter 6). There are very limited 
data reporting the concentration of FFA in fresh EBM, primarily due to the lack of suitable 
technology. Previous research shows that the fat composition of human milk is highly 
variable depending on time of collection, lactation stage, maternal diet [Koletzko 2016]. 
Therefore I planned to collect freshly expressed human milk samples from mothers in the 
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neonatal units to understand the effect of gestation weeks, lactation stage and short period 
storage on the FFA concentration of human milk, which will be presented in Chapter 6.  
In the final chapter (Chapter 7), I discuss emerging areas for future research, including 
examination of the effects of addition of HMF on the human milk lipid profile and other 
potential usages of dried spot technique.  
 
Table 1.1. Outline of the thesis and corresponding publications 
Chapter Study aim Study 
Design 
Conventional thesis or 
publication 
2 To evaluate all evidence 
regarding the changes to breast 
milk fat composition after 
storage, pasteurisation, and 






Leukotrienes and Essential 
fatty acids (2019) 146:1-10 
3 To adapt and test the 
sensitivity and applicability of 
a dried milk spot method for 
profiling total fatty acid 
composition of breast milk 










Leukotrienes and Essential 
fatty acids (2018) 139:3-8 
4 To develop a robust dried milk 
spot method that accurately 
measures free fatty acids 




5 Publication  
 
Prostaglandins, 
Leukotrienes and Essential 
fatty acids (2019) 
6 To determine the variation of 
free fatty acid concentration in 
freshly expressed breast milk 
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7 To discuss the overall findings 
of the studies in this thesis and 




Not applicable  
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Chapter 2 Literature Review - Changes to breast milk fat 
composition during storage, handling, and processing 
 
This review was extended to include the common practices of mothers returned to work but 
continue to feed the infants with EBM, practices that are implied in human milk bank to 
handle donor milk, and new innovative non-thermal pasteurisation techniques to replace the 
conventional holder pasteurisation, as all these procedures can potentially alter the fat 
composition of EBM that is fed to a wider population. Although such EBM might not be fed to 
the preterm population exclusively, the general principles are the same, which is to 
understand the different procedures involved in handling EBM and how it might affect the fat 
composition of EBM.   
 
This chapter includes a manuscript in its published form: 
Gao, C., Miller, J., Middleton, P.F., Huang, Y-C., McPhee, A.J., Gibson, R.A. (2019). 
Changes to breast milk fat composition during storage, handling and processing: a systematic 
review. Prostaglandins, Leukotrienes and Essential Fatty Acids, 146: 1-10. 
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Chapter 3 Adapt and utilize dried milk spot for profiling fatty acid 
composition of breast milk 
 
 
In the previous chapter, it was found that current evidence regarding changes to the fat 
composition of human milk after handling and processing are largely based on old chemical 
techniques that are prone to detection error, and thus the results derived from these studies 
were highly variable and difficult to interpret. Therefore, this chapter and the next two 
chapters (Chapter 4 and 5) focus on the development of modern DMS method for profiling 
human milk fats, with different measurements. This chapter describes the work related to 
adapting a current available dried blood spot method in total fatty acid profiling for human 




This chapter includes a manuscript in its published form: 
Gao, C., Gibson, R.A., McPhee, A.J., Zhou, S.J., Collins, C.T., Makrides, M., Miller, J., Liu, 
G. (2018). Comparison of breast milk fatty acid composition from mothers of premature 
infants of three countries using novel dried milk spot technology. Prostaglandins, 
Leukotrienes and Essential fatty acids, 139: 3-8. 
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Chapter 4 Steps in the journey to develop a micro-sampling system 
for measuring concentrations of free fatty acid in breast milk 
collected as dried spot 
 
 
The DMS method described in the previous chapter fulfilled the needs for an accurate method 
for profiling the total fatty acid composition of human milk, that was also sensitive and 
capable of detecting the subtle differences in fatty acid composition in human milk collected 
from women with different habitual diets. However, it does not fulfill the needs for FFA 
separation and analysis. Therefore, developing a DMS method that specifically measures the 
FFA concentration of human milk is the focus for the current and the next chapter of this 
thesis.  
I made many attempts to develop a DMS method for measuring the FFA concentration of 
human milk, which resulted in varying levels of success. Eventually these attempts led to a 
successful method that has been tested in a clinical study, and this will be discussed in later 
chapters. In this chapter, I describe all partially successful experiments, in the hope that these 
may provide useful evidence for future research in this area.  
There is no publication related to this Chapter.  
  




⚫ Methods for lipids class separation 
The commonly used methods for lipid class separation are the conventional TLC 
method, and emerging techniques such as the high performance liquid chromatography with 
evaporative light scattering detector (HPLC-ELSD) and liquid chromatography tandem mass 
spectrometry (LC-MS/MS). Each of these methods has its own strengths and weakness 
regarding breast milk lipids separation, which are outlined below.  
1) TLC method  
The TLC-GC method generally includes three main steps: lipid extraction, separation, 
and transesterification and analysis. First the lipids are extracted from breast milk (or other 
biological fluids) using organic solvents. The extracted lipids are then spotted on a silica gel 
plate and placed in a tank filled with elution solvents, and the separation of lipids is driven by 
the polarity of individual lipid classes. In the case of breast milk, the four major lipids are 
separated in the following descending order on a plate: cholesterol ester (CE), triglycerides 
(TG), free fatty acid (FFA), and phospholipid (PL). After the separation, the TLC plate is 
taken out of the tank to dry and sprayed on with a thin layer of fluorescent, so that the 
separated lipids can be visualised under ultraviolet light, which allows the FFA band to be 
scraped off for further methylation into FAME and analysed and quantified on gas 
chromatography (GC). This biggest concern with this method is the likelihood of 
contamination during the chromatographic separation process due to the dominant presence of 
TG (>98% of fats in breast milk). A tailing of TG band is often seen that leads to unclear 
separation between TG and FFA, resulting in some TG being scraped off along with FFA 
causing contamination and inaccurate results. The TLC-GC method is also laborious and 
hence has low throughput, but it is common choice as it is relatively cheap to run and only 
requires GC for analysis. It is also important to note that the TLC-GC method not only 
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provides the quantitative information (e.g. the absolute amount of FFA) but also qualitative 
information (e.g. the fatty acid composition of FFA).   
2) HPLC-ELSD method 
There have also been several new methods proposed for separating and identifying lipid 
classes, and the HPLC-ELSD method for this purpose was reported by Olsson and colleagues 
(Olsson et al. 2012). Extracting lipids from breast milk or other biological fluids is still 
necessary, and Olsson et al. used pure lipids dissolved in chloroform and methanol for 
injection into the equipment. The system which Olsson and colleagues descried was a normal-
phase binary gradient HPLC system using a cyanopropyl column, with various solvents 
including hexane, pentane, cyclohexane, octane and heptane tested as solvent A, while solvent 
B was a constant combination of toluene, methanol, acetic acid and triethylamine. The 
separation of all tested lipid classes was clear with sharp and symmetrical peaks identified on 
the chromatograph, in the following ascending order according to retention time: TG, 
diglyceride (DG), monoglyceride (MG), and PL. Although the authors did not use FFA in the 
experiment, it would be expected to be seen between MG and PL based on polarity. 
Compared with the TLC-GC method, this HPLC-ELSD is less laborious but requires a higher 
grade of organic solvents and machines for analysis that increases laboratory costs. In 
addition, this method would only offer the quantitative data but not the qualitative data.  
3) LC-MS/MS 
There have been several reports of the use of LC-MSMS in analysing FFA from various 
sample sources (dried blood spot by Hewawasam et al. 2018, marine algae by Scholotterbeck 
et al. 2018, grape skin and seeds by Perez-Navarro et al. 2019). Regardless of the status (dried 
or liquid) of the sample, the first step also involves lipid extraction, which is then injected into 
the LC-MS/MS for quantification of individual FFA. This method is also less laborious than 
the TLC method as it encompasses the separation and analysis step which is completed within 
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the same run of the chromatograph. However, this method requires advanced machines that 
might not be easily accessed for all laboratories.  
In summary, current available methods for separating lipid classes are either prone to 
detection errors but are less costly (TLC method) or provide accurate result at a much higher 
cost (HPLC-ELSD and LC-MS/MS). The optimal goal would be to use the least expensive 
resources to obtain accurate measurements. It is important to keep in mind that though this 
might not be a concern for other biological fluids, due to the dominance of TG in breast milk 
fats, even a 1% TG contamination of the sample could mean an over 50% increase in the 
detected FFA concentration. 
⚫ The proposed method for FFA separation  
The challenges for new techniques for the analysis of breast milk fats are that they 
should aim to minimise the volume required for analysis, particularly as EBM is often in short 
supply for preterm infants. In many of the large clinical trials conducted in recent years, the 
benefits of using dried spot system and thus eliminating the needs of cold chain transportation 
and storage has greatly reduced research expenses. Therefore, for the purpose of this thesis, 
any proposed method was required to have the following characteristics: a filter paper based 
collection system that 1) requires only micro-amounts of sample; 2) provides accurate and 
robust measurement of FFA without contamination from TG; 3) is stable at room temperature 
for long periods. Methods recorded in this chapter were considered unsuccessful if they were 
not able to meet all the criteria described above.  
⚫ Common characteristics of experiments described in this chapter  
Two types of collection paper were tested in these experiments: the 903 paper 
(Whatman 903 specimen collection paper, commonly used for inborn errors of metabolism in 
newborns) and silica gel impregnated ion exchange paper (Whatman SG81 ion exchange 
paper), which will be referred as 903 and SG paper in this chapter, respectively. All collection 
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papers used in these experiments were sized into paper discs with diameter of approximately 
1 cm.  
Two gas chromatographs with flame ionisation detector (GC-FID) were used in these 
experiments described blow.  
❖ For fatty acid methyl esters (FAME) analysis: GC (Agilent Technology 7890B, 
Santa Clara, CA, USA) was equipped with a BPX70 column 50m × 0.32 mm, 
film thickness of 0.25µm (Trajan Scientific Australia Pty Ltd), the temperature 
ramp was set to be 140℃ to 220℃, and helium flow was at 2ml/min and a split 
ratio of 20:1.  
❖ For underivatized FFA analysis: GC (Hewlett-Packard 6890, Palo Alto, CA, USA) 
was equipped with a BP column cut to 10m × 0.25mm, film thickness of 0.25 µm 
(Trajan Scientific Australia Pty Ltd) with a temperature ramp form 180℃ to 240℃, 
helium flow of 3ml/minute and split ratio of 20:1. 
The FAME and FFA were identified based on the retention time of a mixed commercial 
reference standards purchased from NuCheck (Nu-Check Prep, Inc., MN, USA). 
As GC-FID was used to analyse FAME derived from fatty acids of different structural 
lipids, I have used lipids that contain only a single fatty acid (different fatty acids for each 
lipid class) in order to identify the source of origins of fatty acids. As this was an 18-month 
progress of method development, during which time I ran out of certain standards and have 
re-purchased or purchased new ones, the lipid mixture used in the experiments described in 
this chapter was dependent on the availability at the time and was not entirely the same across 
different experiments. However, the preparation of lipid mixture always featured TG. Certain 
lipids like CE sometimes were not present in the lipid mixture because it was not a major 
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source of contamination, but was in the lipid mixture for a more complete representation of 
breast milk lipids.  
Table 4.1. Detail of the lipid standard (commercial products purchased from chemical 









and proportion in the 
mixture) 
Source of purchase Section 
A TG 13:0 9.6 mg/ml, 40% NuChek Prep Inc 5.1 & 
5.2  FFA 14:0 9.4 mg/ml, 15% NuChek Prep Inc 
PL 20:0 11.8 mg/ml, 15% Sigma-Aldrich 
CE 17:0  10.1 mg/ml, 15% NuChek Prep Inc 
DG 18:1  9.75 mg/ml, 15% Sigma-Aldrich 
B TG 13:0 9.87 mg/ml, 40% NuChek Prep Inc 5.3-part 
1 FFA 14:0 9.4 mg/ml, 20% NuChek Prep Inc 
PL 17:0 11.2 mg/ml, 20% NuChek Prep Inc 
DG 18:1  12.5 mg/ml, 20% Sigma-Aldrich 
C TG 13:0 10.3 mg/ml, 25% NuChek Prep Inc 5.3 part 
2, 5.5, 
5.6  
 22:6 n-3 10 mg/ml, 25% NuChek Prep Inc 
FFA 12:0  11.5 mg/ml, 10% NuChek Prep Inc 
 20:0 9.4 mg/ml, 10% NuChek Prep Inc 
DG 18:1 12.6 mg/ml, 10% Sigma-Aldrich 
PL  22:1 10.3 mg/ml, 10% Sigma-Aldrich 
CE 17:0 10.1 mg/ml, 10% NuChek Prep Inc 
D TG 13:0 4.7 mg/ml, 60% NuChek Prep Inc 5.4 Part 
1 FFA 14:0 5.4 mg/ml, 25% NuChek Prep Inc 
CE  17:0 5.4 mg/ml, 10% NuChek Prep Inc 
PL 20:0 4.7 mg/ml, 5% NuChek Prep Inc 
E TG 13:0 10.3 mg/ml, 20% NuChek Prep Inc 5.4-part 
2  22:6 n-3 10 mg/ml, 20% NuChek Prep Inc 
FFA 12:0  11.5 mg/ml, 10% NuChek Prep Inc 
 20:0 9.4 mg/ml, 10% NuChek Prep Inc 
DG 18:1 12.5 mg/ml, 20% Sigma-Aldrich 
PL  17:0  11.2 mg/ml, 20% NuChek Prep Inc 
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Table 4.2. Summary of all experiments at a glance 
Section and Name 
 5.1 Selective 
methylation of 















extraction of free 
fatty acids from 
breast milk collected 
as dried spot 
5.5 Separating free 




5.6 Separating free 
fatty acids by 






Free fatty acids, 





due to the 






was hoped that 








reaction is ceased 
by addition of 
pyridine. Same 
principle as 







to fatty acid 
methyl ester but 
unable to esterify 
free fatty acids, 
therefore free 
fatty acids can be 
separated once 
transmethylation 
is completed.  
Lipids present in 
breast milk all have 
different polarities 
which affect the 
extraction efficiency 
of lipids bound to 
collection paper. 
Certain solvent may 
be able to extract 
only lipids with high 
or low polarity and 
leave the others on 
the paper. 
A conventional 
method for lipid 
classes separation 
based on their 
polarity, similar 








Free fatty acids 
should be able to 
bind with paper that 
is treated with anion 
or basic condition 
due to its chemical 
property, and 
therefore can be 
separated from other 




n paper  
903 903 903 903 and SG Nil  903 and SG 









domestic and deep 
freezer 
 
Reaction time: 10, 




(0.01%, 0.1%. 1% 
sulphuric acid in 
methanol) 
























acid methyl ester 
from free fatty 
acids 










Using solid phase 
extraction column 
material for pilot 
run, with pure 
standards in liquid 
status   
Various pH 
condition and 
combination of salts 
 
Stability of breast 
milk collected on 
alkaline coated paper  
GC 
analysis 
Fatty acid methyl 
ester 
Fatty acid methyl 
ester 
Fatty acid methyl 
ester 
Fatty acid methyl 
ester 














rather than Fatty 















No single solute 
could separate free 
fatty acids from 
triglycerides 
Difficulties with 






separation of free 





triglycerides due to 
pH coating of the 
filter paper 
 
Lipases in breast 
milk remain active 
even when collected 
as dried spot 
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4.1 Selective methylation of free fatty acids in an acid-catalysed condition  
4.1.1 Rationale 
The lipids present in human breast milk have different structures and levels of 
complexity. FFA, being unesterified, have the simplest structure and it has been hypothesised 
to be methylated first relative to other structural lipids present in breast milk [Christie et al. 
1993; Gros et al. 1964; Hartman et al. 1965]. The standard method used in our lab for fatty 
acid methylation and transmethylation takes place in 1% sulphuric acid in methanol solution 
at 70℃ for three hours [Liu et al. 2014]. During the three-hour time frame, fatty acids from 
all lipids, regardless of their original structure, will be transmethylated or methylated into 
FAME, which can then be identified by the GC based on retention time of reference 
standards. If the time, or temperature, or the concentration of acid in the reacting solvent can 
be controlled so that only FFA are methylated and other lipids remain intact, then only FFA 
derived FAME will be identified and recognised by GC. My working hypothesis was that by 
extending the range of conditions tested by others it might be possible to selectively methylate 
FFA without transmethylating the more complex lipids.  
4.1.2 Materials and methods 
In order to be able to test the effectiveness of various procedures in separating FFA 
from other lipid fractions, I have used lipid standard mixture A (containing FFA, TG, CE and 
PL) listed in Table 4.1.  
Twenty microliters of the lipid standard mixture were collected on discs of 903 paper, 
air-dried and the paper discs were then transferred to 6ml scintillation vials, then 2ml 
transmethylation solvent (with 1%, 0.1% and 0.01% sulphuric acid in methanol) was added 
and left at room temperature (at fridge for 1%) for 10, 20, 30, 45 or 60 (120) minutes.  
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At the time of analysis, the paper discs were removed from the vial and transferred to 
another set of 6ml scintillation vials containing 2ml of transmethylation solvent and heated to 
70℃ for 3 hours to determine lipids that remain bound to the paper. Half of the original 
transmethylation solvent was transferred to a separate vial, the FAME were extracted with 
heptane to determine the lipids that had been transmethylated during the time of experimental 
period. The other half of the transmethylation solvent remained in the vial was heated to 70℃ 
for 3 hours and resulting FAME were analysed to determine the lipids that had been leached 
off the paper discs, but yet to be transmethylated. All FAME were analysed by GC-FID and a 
flow diagram of the experimental process is shown below (Figure 4.1.1). All samples were 
tested in triplicates. 
 
 
Figure 4.1.1. A flow diagram of the experiment 
4.1.3 Results and discussion  
All data are expressed as percentage of fatty acids transmethylated/methylated from 
each lipid class based on their peak area (PA).  
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% 𝑜𝑓 𝑙𝑖𝑝𝑖𝑑𝑠 𝑡𝑟𝑎𝑛𝑠𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑒𝑑/𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑒𝑑
=  
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑖𝑛 𝑠𝑜𝑙𝑣𝑒𝑛𝑡 𝑎 ∗ 2 
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑖𝑛 𝑠𝑜𝑙𝑣𝑒𝑛𝑡 𝑏 ∗ 2 + 𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑜𝑛 𝑠𝑝𝑜𝑡𝑠
∗ 100 
 
% 𝑜𝑓 𝑙𝑖𝑝𝑖𝑑𝑠 𝑟𝑒𝑚𝑎𝑖𝑛𝑒𝑑 𝑏𝑜𝑢𝑛𝑑 𝑡𝑜 𝑡ℎ𝑒 𝑐𝑜𝑙𝑙𝑒𝑐𝑡𝑖𝑜𝑛 𝑝𝑎𝑝𝑒𝑟
=  
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑜𝑛 𝑠𝑝𝑜𝑡𝑠 
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑖𝑛 𝑠𝑜𝑙𝑣𝑒𝑛𝑡 𝑏 ∗ 2 + 𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑜𝑛 𝑠𝑝𝑜𝑡𝑠 
∗ 100 




Figure 4.1.2. Completion of transmethylation of a mixture of lipid standard in 1% sulphuric 
acid in methanol in refrigerator (top) and at room temperature (bottom) over 60 minutes. 
FFA: free fatty acid (C14:0); TG: triglyceride (C13:0); DG: diglyceride (C18:1); CE: 
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Figure 4.1.3. Completion of transmethylation of a mixture of lipid standard in in 0.1% (top) 
and 0.01% (bottom) sulphuric acid in methanol at room temperature over 120 minutes. FFA: 
free fatty acid (C14:0); TG: triglyceride (C13:0); DG: diglyceride (C18:1); CE: cholesterol 
ester (C17:0); PL: phospholipid (C20:0). 
 
Regardless of the conditions tested, no one method fulfilled the criteria of only 
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to FAME in 1% sulphuric acid in methanol within 60 minutes or 20 minutes in the 
refrigerator or at room temperature, respectively. However, 4.4% and 1.5% of TG, and 11.3% 
or 12.1% of DG were also transmethylated into FAME at these conditions during the same 
time frame, respectively (Figure 4.1.2 & 4.1.3). It was clear that changing the temperature 
from 23℃ to 5℃ had little effect on the rate of transmethylation of the test lipids. Lowering 
the acid concentration in the transmethylation solvent only slowed the reaction and extended 
the period of FFA took to be converted to FAME. Lowering the percentage of sulphuric acid 
from 1% to 0.1% yielded the best result with nearly all FFA (93.8%) being converted to 
FAME in two hours and only 3.0% of TG being converted to FAME. Decreasing the 
concentration of sulphuric acid 10-fold further resulted in few lipids being converted. It is 
possible to further workout a specific condition where only certain percentage of FFA was 
converted to FAME while none of other lipids are transesterified, and then to estimate the 
total FFA. However, the concentration of FFA in breast milk could vary significantly 
depending on the storage and handling procedure that has been experienced [Gao et al. 2019; 
Nessel et al. 2019], and it is likely that the rate of transmethylation is concentration dependent 
and thus less practical to have a universal equation. 
In addition, before formally attempting this method of selectively methylating FFA by 
manipulating the reaction time and temperature, I performed several test trials that resulted in 
some variations likely due to the temperature. The time taken for completing FFA 
transmethylation ranged between 20 to 30 minutes and percentage of TG being 
transmethylated during this time frame ranged between 1.8% and 4.4%. The reaction solvent 
(1% sulphuric acid in methanol) used in the lab is stored in the fridge to preserve the acid 
concentration. It was found that the temperature of the transmethylation solvent (whether 
taken straight out of fridge or being left out at room temperature prior to use) contributed to 
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the variation observed. This observation suggest that the current method is highly temperature 
sensitive and therefore less practical in field.  
 
 
Figure 4.1.4. Distribution of lipid classes on paper disc after being transmethylated in 1% 
sulphuric acid in methanol at room temperature for 10, 20, 30, 45 and 60 minutes FFA: free 
fatty acid (C14:0); TG: triglyceride (C13:0); DG: diglyceride (C18:1); CE: cholesterol ester 
(C17:0); PL: phospholipid (C20:0).. 
 
To understand the distribution of all lipids at different time points during the 
transmethylation process, whether remaining bound to the collection paper or being eluted 
into the solvent, the paper discs were transmethylated separately. Most of the lipids were 
eluted from the collection paper into the solvent following a time-dependent manner for 
transmethylation (Figure 4.1.4). DG and TG acted like FFA, being washed off the collection 
paper almost immediately except very small portion remained bound to the paper. PL, a polar 
lipid that were washed off with a polar solvent mixture but were remained in intact under the 
same condition (Figure 4.1.2 bottom). In contrast, CE, the most non-polar lipids of all in 
breast milk, tend to remain bound to the collection paper throughout the reaction time, where 
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the potential of selectively eluting some lipid classes off the collection paper while others 
remain bound to the paper. 
4.1.4 Conclusion  
 
The results of these experiments are in agreement with the literature that lipids in breast 
milk are being transmethylated at different rates based on their chemical structures. However, 
the method of altering the time, temperature or acid concentration of transmethylation solvent 
to selectively convert FFA to FAME has failed to achieve the goal of separating FFA from 
breast milk without being contaminated by TG and other lipids in breast milk. 
 
4.2 Selective methylation of free fatty acids in an acid-catalysed condition 
4.2.1 Rationale 
Based on the principle that ‘non-esterified FFA should be converted to FAME prior to 
other more complexed lipids under the same condition’ as described in the previous section, 
Tserng and colleagues [Tserng et al. 1981] reported a different acid-catalysed methylation, 
where all FFA were methylated within 15 minutes at room temperature while there was 
minimal conversion of all other esterified lipids during the same period. This acid-catalysed 
method used dimethoxypropane (DMP) and hydrochloric acid (equivalent to 2%) together 
with liquid plasma and the reaction was terminated by the addition of a small amount of 
pyridine. Differing from the methylation solvent used in my lab, this methylation method 
described by Tserng [Tserng et al. 1981] appeared to allow direct methylation of liquid 
biological fluid without a fat extraction/purification step. Unlike the sulphuric acid /methanol 
system, the presence of water in the DMP/hydrochloric acid system was reported to not 
interfere with the reaction but generates methanol to promote the reaction. In this system, 
DMP has three different roles: (a) acting as a water scavenger, (b) to precipitate protein and 
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(c) to offer methyl groups in the presence of water and acid as shown in the chemical equation 
below (Figure 4.2.1). 
 
Figure 4.2.1. Reaction between dimethoxypropane and water under an acid-catalysed 
condition to produce acetone and methanol. 
 
It was hypothesized that this method can be modified and adopted into a DMS based 
system with small adjustment to the volume of DMP and hydrochloric acid added due to 
potentially higher concentration of FFA in breast milk compared with plasma, and less DMP 
may be required due to the absence of water in a DMS system.  
4.2.2 Materials and methods  
In the original manuscript [Tserng et al. 1981], methanol acted as the carrier solvent for 
internal standards. For the purpose of replicating all details I have decided to add the same 
volume of methanol. However, considering that the level of fats and therefore FFA should be 
much higher than that in plasma, the volume of methanol was further increased to assist the 
methylation process. The volume and ratio of HCl to pyridine was kept constant, as 
hydrochloric acid acted as a catalyst for the reaction (and only requires a relatively small 
volume) and the sole purpose of adding pyridine was to terminate the reaction.  
As this was an exploratory test and by no mean I could directly measure the completion 
of transmethylation by the DMP method, therefore a standard transmethylation process 
described in section 4.1 (1% sulphuric acid in methanol and heated at 70℃ for three hours) 
was set up as the control group. 
Chapter 4                                   DMS method for FFA measurement 
60 
 
Twenty microliters of the lipid standard mixture (A in Table 4.1) were collected on 903 
paper discs, air-dried, and then transferred to 6ml scintillation. The solvents were added in the 
vial in the following order as described in the literature [Tserng et al. 1981]: water, methanol, 
DMP, hydrochloric acid and pyridine, in various volumes and ratios as detailed in Table 4.2.1 
(for results see 4.2.2) and 4.2.3 (for results see 4.2.4). Fifteen minutes of reaction time was 
allowed, counting from the addition of HCl. After the addition of pyridine, resulting FAME 
was extracted with 500µL of water and 500µL of heptane, which was then analysed on GC-
FID. All samples were analysed in triplicates.  
4.2.3 Results and discussion 
All data are expressed as percentage of fatty acids transmethylated from each lipid class 
based on their peak area (PA).  
% 𝑜𝑓 𝑙𝑖𝑝𝑖𝑑𝑠 𝑡𝑟𝑎𝑛𝑠𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑒𝑑 =  
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑓𝑜𝑟𝑚𝑒𝑑 𝑢𝑠𝑖𝑛𝑔 𝐷𝑀𝑃 𝑚𝑒𝑡ℎ𝑜𝑑
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑓𝑜𝑟𝑚𝑒𝑑 𝑢𝑠𝑖𝑛𝑔 𝑡ℎ𝑒 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑚𝑒𝑡ℎ𝑜𝑑
∗100 
Table 4.2.1. The solvent make-up used in the part 1 experiment to determine the feasibility of 








50 50 50 - 50 50 50 
Methanol 25 25 - 25 25 200 500 
DMP 1000 1000 1000 1000 500 1000 1000 
HCl 20 20 20 20 20 20 20 
Pyridine 10 10 10 10 10 10 10 
Note: Group 0 lipid mixture was spotted directly into a 6ml scintillation vial; Group 1-6, 
lipids mixture was collected on 903 paper discs prior to reaction. H2O: water. HCl: 
hydrochloric acid. H2SO4: sulphuric acid. 
 
Table 4.2.2. Completion of transmethylation for each lipid class using the dimethoxypropane 
(DMP) method (%) compared with the standard transmethylation method, results 






0 1 2 3 4 5 6 
TG 13:0 0.9 1.2 1.1 - 1.1 1.1 1.5 
FFA 14:0 34.0 57.4 48.6 12.6 40.5 49.8 67.5 
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CE 17:0 - - - - - - - 
DG 18:1 - - - - - - - 
PL 20:0 - - - - - - - 
Note: TG: triglyceride; FFA: free fatty acid; CE: cholesterol ester; DG: diglyceride; PL: 
phospholipid. Standard transmethylation method was with 1% sulphuric acid in methanol for 
three hours at 70℃. 
 
Regardless of the experimental conditions tested, none fully converted FFA to FAME 
but around 1% of TG was transmethylated in each of the treatment groups. The positive result 
was that other esterified lipids including CE, DG and PL remained intact as there were no 
FAME derived from these lipids detected and therefore were not a source of contamination in 
such a system (Table 4.2.2). Comparing results 0 and 1, incorporating a dried spot into the 
method actually enhanced the methylation for FFA, which demonstrated that this method had 
a potential to be adapted into a dried spot-based system (Table 4.2.2). Comparing result 1 and 
3, with small amount of methanol, the methylation cannot proceed at the absence of water to 
produce methyl groups (Table 4.2.2). However, with absence of methanol, the methylation 
could still take place as water reacts with DMP to produce methanol. Addition of methanol 
could probably increase the proportion of FFA being transmethylated as comparing result 1 
and 6 (Table 4.2.2).  
There might be two reasons that FFA were not fully transmethylated. First, there might 
not be enough methyl groups (methanol) for all FFA to be converted to FAME, as the fat 
content of plasma is far less than that in breast milk. Second, it is suspected that 15 minutes 
was not enough to allow all FFA in such a lipid standard mixture to be methylated 
completely. Further experiments were conducted to explore the different ratio and makeup of 
the reaction solvent to maximize the conversion from FFA to FAME. 
In addition to the results presented in the table above, I also noticed that in the gas 
chromatograph, there was a peak present adjacent to the FFA (C14:0)-FAME peak, which 
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was suspected to be a by-product formed during the process and may be a by-product of FFA. 
This by-product was presented in all samples of experimental group with a similar peak area 
of 60, except for experimental group 4 where only half the volume of DMP was added into 
the reaction (peak area was 25), thus the by-product may also be dependent on the volume of 
DMP used. Therefore, further experiments were conducted to investigate the source of the by-
product in the hope of eliminating it. 
 
The second part of the experiment was conducted to investigate the cause of the by-
product peak observed in part 1 experiment and to further optimize the system for complete 
methylation of FFA.  
Table 4.2.3. The solvent makeup of the part II experiment to investigate source of by-









50 50 50 100 250 500 50 50 - 
Methanol 25 25 25 25 25 25 50 1000 1000 
DMP 1000 250 50 1000 1000 1000 1000 1000 1000 
HCl 20 20 20 20 20 20 20 20 20 
Pyridine 10 10 10 10 10 10 10 10 10 
Note: Blank was where no lipid mixture was involved, only solvents were added. Group 1-8, 
lipids mixture was collected on 903 paper discs prior to reaction. H2O: water. HCl: 
hydrochloric acid. H2SO4: sulphuric acid. 
 
Table 4.2.4. Completion of transmethylation of each lipid class using the dimethoxypropane 
(DMP) method (%) as compared with the standard transmethylation method, results 





Blank 1 2 3 4 5 6 7 8 
TG 13:0 - - - - - - 0.8 0.9 1.0 
FFA 14:0 - 14.6 3.0 21.6 2.2 - 45.9 50.8 41.5 
CE 17:0 - - - - - - - - - 
DG 18:1 - - - - - - - - - 
PL 20:0 - - - - - - - - - 
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Note: TG: triglyceride; FFA: free fatty acid; CE: cholesterol ester; DG: diglyceride; PL: 
phospholipid. Standard transmethylation method was with 1% sulphuric acid in methanol for 
three hours at 70℃. 
 
Due to the suspected by-product peak observed in the previous experiment, I decided to 
run a blank sample to further investigate the source of the peak. ‘Blank’ contained no lipid 
standard but only reagent solvents were added and the by-product was also found with similar 
peak area of 52.4, which confirmed that the by-product was formed during the reaction and 
was independent of any lipids (Table 4.2.4). There have been other reports of formation of 
artifacts in the methylation process using DMP solution, which were eliminated once DMP 
had been removed from the system [Mason et al. 1964; Shimasaki et al. 1976; Simmonds et 
al. 1965] 
The effect of adjusting the ratio of different solvents in order to maximize the 
conversion from FFA to FAME was not successful. Where the proportion of DMP was 
reduced (No 1&2 in Table 4.2.4), there was less FFA derived FAME detected, which was 
likely due to insufficient methyl groups for methylation and/or the presence of water in the 
solution likely stopped the reaction. However, increasing the volume of methanol in such 
system did not enhance the methylation of FFA (67.5% in No. 6 Table 5.2.3 with 500µl 
methanol versus 50.8% in No. 7 Table 4.2.4 with same other conditions applied). This poorer 
methylation efficiency may be related to the subtle difference between acid concentration 
(approximately 1.3% versus 1%).  
Combining the results from the two experiments, the highest conversion rate from 
FAME to FFA (67.5%) was seen where additional methanol (500µl) was added, besides 
standard amount of DMP (No. 6 in Table 4.2.2). However, under such conditions, 1.5% of TG 
had also been converted to FAME whilst FFA has not yet completely been methylated. 
Among all tested conditions, there was no CE, DG or PL derived FAME detected.  
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There was no further exploration of extending the reaction time, because the FFA 
concentration in breast milk varies depending on past treatments [Gao et al. 2019; Nessel et 
al. 2019]. Trace amounts of FFA are expected in freshly expressed breast milk and higher 
concentrations of FFA are expected in breast milk that has been stored or pasteurised, 
therefore it is difficult to define the best time frame for such methylation process. As shown 
in this experiment, 1.5% of TG was converted to FAME during the time that there were still 
FFA remaining to be methylated, and thus extending methylation time would also increase the 
methylation for both lipids and therefore defeating the purpose.  
4.2.4 Conclusion 
The DMP method for direct and selective transmethylation of FFA failed to work as all 
FFA were not fully converted to FAME in any of the tested conditions, while at the same 
time, a small proportion of TG had already been transmethylated. In the context of separating 
breast milk fats, this method was considered not appropriate as the trace contamination from 
TG has a significant impact on the reading of FFA concentration due to its dominance in 
breast milk fats. Nevertheless, this method still has potential relevance for other biological 
fluids (e.g. plasma sample used in the original manuscript) where the lipid composition is not 
dominated by TG and the contamination from TG is negligible. There was no mention of the 
by-product peak observed in the original manuscript [Tserng et al. 1981]., which should be 
further investigated if one was to adapt this method for lipid class separation.  
4.3 Selective transmethylation of esterified lipids in basic-catalysed condition 
4.3.1 Rationale 
Besides the acid methylation/transmethylation method described previously in 4.1, 
where all lipids (regardless of esterified or non-esterified) can be transmethylated or 
methylated into FAME. A base-catalysed transmethylation is often reported in the literature 
[Akoh et al. 1988; Glass et al. 1971; Hubscher et al. 1960; Malko et al. 2019] that selectively 
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transmethylates all esterified lipids (TG and its degraded by-products diglycerides and 
monoglycerides, as well as CE and PL) while unable to esterify FFA, and this reaction only 
takes minutes to complete. My working hypothesise was a two-step transmethylation process, 
where the basic condition offered the ability of selectively transmethylate all esterified lipids 
into FAME. FFA can then be separated from FAME derived from those esterified lipids, and 
then be methylated into FAME in an acid-catalysed condition described previously in section 
4.1.  
4.3.2 Materials and methods 
A preliminary test was conducted to test the feasibility of this method in a dried spot 
system. A lipid standard mixture containing TG, FFA, PL and DG was used (lipid mixture B 
in table 4.1). This mixture did not contain CE due to the unavailability at the time, and CE 
only present in human milk in trace amount, which was not considered a major source of 
contamination.  
Twenty microliters of the lipid standard were added to 903 paper discs, dried and then 
transferred to 6ml scintillation followed by addition of 2ml petroleum spirit (vial 1). Either 
100µL of sodium or potassium methoxide (2N, prepared from sodium or potassium hydroxide 
and methanol) was added into the 6ml vial, and reaction time allowed was 10, 20 or 30 
minutes. At the end of reaction, the paper discs were taken out and transferred to another 6ml 
scintillation vial (vial 2) for transmethylation in 2ml of 1% sulphuric acid in methanol to 
determine lipids that remain bound to the paper. Then, 250µL of water was added to vial 1 
and vortexed. Following phase separation, the upper layer containing fatty acids that were 
esterified during the treatment was then taken to another 6ml scintillation vial (vial 3). Half of 
the solvent in vial 3 was transferred to another 6ml scintillation vial (vial 4), 600µL of 
heptane was added and FAME was extracted for GC analysis, which measures half of the 
FAME formed during the basic transmethylation process. The remaining solvent in vial 1 and 
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3 were dried under a steady nitrogen flow and then transmethylated in 2ml of 1% sulphuric 
acid in methanol at 70℃ for three hours. Vial 1 represented the fatty acids that had been 
leached off the paper but were not esterified during the basic transmethylation, and vial 3 
contained the other half of FAME formed during the basic transmethylation and also 
unesterified fatty acids that were not merged into the water phase in vial 1.  
 
Figure 4.3.1. Preliminary test of the basic transmethylation system.  
 
A further exploration was conducted to reduce the contamination of TG in this system. 
Twenty microliters of a mixed lipid standard (Lipid mixture C in Table 4.1, contained TG, 
FFA, PL, CE, and DG) was added to 903 paper discs, which were dried and transferred to 6ml 
scintillation vials. A basic transmethylation step was conducted in the same way described 
Chapter 4                                   DMS method for FFA measurement 
67 
 
above: 2ml of petroleum spirit and 100µL of sodium methoxide (2N) was added into the vial 
(vial 1), vortexed and allowed 30 minutes for reaction at room temperature. At the end of 
transmethylation, 500µL of water was added to enforce phase separation and the upper layer 
that contained FAME formed during the basic transmethylation was transferred to another 
6ml scintillation vial (vial 2). An additional 2ml of petroleum spirit was added into vial 1, 
vortexed and the upper layer that contained any possible left-over FAME from previous step 
was transferred to another 6ml vial (vial 3). After the content in all three vials has been dried 
under nitrogen flow, 600µL of heptane was added to vial 2 and 3 to extract the FAME derived 
from neutral lipids; 2ml of 1% sulphuric acid in methanol was added in vial 1 for 
transmethylation to measure the concentration of FFA, the FAME derived was extracted with 
water and heptane and analysed on GC.  
 
Figure 4.3.2. The flow diagram of additional wash of petroleum spirit to remove 
excessive triglyceride causing contamination. 
 
4.3.3 Results and discussion  
 
Table 4.3.1. A preliminary experiment of the basic solution transmethylation method 
based on a single sample (% of lipid classes presented in each vial calculated based on 
peak area), corresponding to figure 4.3.1. 




















Vial 1 – lipids that remained on paper 
discs 
1.3 36.2 10.3 2.3 
Vial 2 – lipids that leached of the paper 
but not esterified during treatment  
0.9 56.6 5.3 5.0 
Vial 3 – lipids that were esterified 
during treatment plus non-esterified 
lipids forced into petroleum spirit layer 
48.9 3.6 42.2 46.3 
Vial 4 – lipids that were esterified 
during the treatment 





Vial 1 – lipids that remained on paper 
discs 
1.0 33.3 5.5 1.4 
Vial 2 – lipids that were not esterified 
during treatment   
2.0 61.8 9.6 9.2 
Vial 3 – lipids that were esterified 
during treatment plus non-esterified 
lipids forced into petroleum spirit layer 
48.5 2.4 42.4 44.7 
Vial 4 – lipids that were esterified 
during the treatment 





Vial 1 – lipids that remained on paper 
discs 
1.1 34.2 4.7 1.4 
Vial 2 – lipids that were not esterified 
during treatment   
1.1 56.1 6.4 5.4 
Vial 3 – lipids that were esterified 
during treatment plus non-esterified 
lipids forced into petroleum spirit layer 
48.9 4.9 44.4 46.6 
Vial 4 – lipids that were esterified 
during the treatment 





Vial 1 – lipids that remained on paper 
discs 
1.1 31.1 10.9 2.7 
Vial 2 – lipids that were not esterified 
during treatment   
0.7 65.1 4.9 1.6 
Vial 3 – lipids that were esterified 
during treatment plus non-esterified 
lipids forced into petroleum spirit layer 
49.1 1.9 35.9 41.2 
Vial 4 – lipids that were esterified 
during the treatment 





Vial 1 – lipids that remained on paper 
discs 
1.0 33.2 8.6 1.6 
Vial 2 – lipids that were not esterified 
during treatment   
0.8 62.2 5.5 2.8 
Vial 3 – lipids that were esterified 
during treatment plus non-esterified 
lipids forced into petroleum spirit layer 
49.1 2.3 42.9 47.8 
Vial 4 – lipids that were esterified 
during the treatment 
44.8 0 35.2 39.7 







Vial 1 – lipids that remained on paper 
discs 
1.1 36.1 5.6 1.5 
Vial 2 – lipids that were not esterified 
during treatment   
1.1 57.9 5.5 3.4 
Vial 3 – lipids that were esterified 
during treatment plus non-esterified 
lipids forced into petroleum spirit layer 
48.9 3.0 44.5 47.6 
Vial 4 – lipids that were esterified 
during the treatment 
48.7 0 36.8 39.9 
Note: TG: triglyceride; FFA: free fatty acid; PL: phospholipid; DG: diglyceride. 
Ideally, FFA should be captured in vial 1 and 2 while all esterified lipids derived FAME 
should be captured in vial 3 and 4. From the results of these tests, it seems likely that 
transmethylation of the esterified lipids were completed within 10 minutes as the neutral 
lipids are equivalent in vial 3 and 4, which is consistent with the literature (Table 4.3.1). FFA 
derived FAME was detected in vial 3 but not vial 4, which is consistent with the literature 
demonstrating that the basic transmethylation method only works for esterified lipids but not 
for FFA (Table 4.3.1). However, this also showed that small percentage (approximately 4-
6%) of FFA was eluted from the paper and released into the petroleum spirit solvent (vial 3), 
which can be corrected by addition of internal standard as majority of the FFA are either 
bound to the paper (vial 2) or in the sodium/potassium methoxide layer (vial 1) (Table 4.3.1).  
The results of this experiment pointed a direction ahead, as at the end of the reaction, 
addition of water trapped all FFA in the sodium/potassium and paper discs layer (vial 1+2), 
whereas FAME derived from all other neutral lipids are extracted to the petroleum spirit 
layer. However, this method was not considered successful due to contamination of TG 
derived FAME, where a total of 2% TG derived FAME can still be found on the paper discs 
and in the sodium or potassium methoxide layer (vial 1+2, Table 4.3.1). Further explorations 
are to be set to increase the number of washes to further extract TG.   
The use of sodium or potassium methoxide generated almost no difference in the results 
seen in this experiment described above, in term of transmethylation efficiency. However, it 
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was observed that the layer separation was clearer and more apparent with sodium methoxide 
than potassium methoxide, therefore the former one was used in the following experiment.  
Table 4.3.2. Distribution of lipid classes in each compartment of the reaction reagent (% of 
total lipid classes based on peak area), results corresponding to the further experiment 
described in figure 4.3.2 








Vial 1 – All unesterified fatty 
acids  
1.8 15 3.6 0 
Vial 2 – FAME formed 
during treatment  
96.8 82.6 94.4 83.5 
Vial 3 – FAME formed 
during treatment but leached 
into water phase  
1.3 2.5 83.5 16.5 
Note: TG: triglyceride; PL: phospholipid; DG: diglyceride; CE: cholesterol ester 
 
This part of the experiment was designed to further extract any leftover FAME derived 
from TG with petroleum spirit, a reaction time of 30 minutes was followed to ensure a 
completed transmethylation. 
In previous experiments, it was observed that at the end of transmethylation where 
FAME derived from esterified lipids had mostly been extracted but small amount of TG 
(2~3%), DG (5~7%) and PL (~15%) were detected in the layer where ideally only contain 
FFA (sodium methoxide layer and on the paper discs, Table 4.3.1). It was hypothesized that 
an additional wash of petroleum spirit at the end of reaction could have fully extracted the 
left-over TG in the sodium methoxide/paper discs layer. However, although the majority of 
the esterified lipids were extracted completely by the additional wash of petroleum spirit, 
there was still approximately less than 2% of TG left on the paper discs and in the water layer 
along with 3.6% of DG and 15% of PL (Table 4.3.2, vial 3). It is likely that fatty acids from 
the TG fraction were liberated from the structural lipids during the process in preparation for 
transmethylation, and hence found in the water and sodium methoxide layer. This was 
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suspected due to the concentration of sodium methoxide, as one step further was taken to 
increase the concentration of sodium methoxide by using an over-saturated sodium methoxide 
solution for reaction. However, this offered similar results and did not reduce or eliminate the 
2% of TG present in the water/sodium methoxide layer, and hence the results were not shown 
here. In addition, the numbers of petroleum spirit wash es was increased from two to four (for 
the same purpose of eliminating TG presented in water/sodium methoxide layer), this did not 
change the results either and therefore results are not presented here.  
4.3.4 Conclusion 
The base solution transmethylation method selectively transmethylated all esterified 
lipids within very short period, and was unable to esterify FFA. However, FFA cannot be 
separated from the rest of lipids without a small percentage of TG contamination. Though this 
is another method considered failed for the purpose of separating breast milk lipids due to the 
TG contamination, it is possibly a promising two-step separation method (first basic 
transmethylation for all neutral lipids and then acidic transmethylation for FFA) for other 
biological fluids where trace contamination from TG is negligible.  
 
4.4 Selective extraction of FFA from a dried milk spot  
4.4.1 Rationale 
In addition to the complexity of structures, lipids in breast milk are also different in 
terms of polarity, which affects the extraction efficiency of lipids bound to a filter paper. As 
observed in section 4.1, some lipids remained bound to the collection paper while others had 
been eluted into the solvent. In this next experiment, the hypothesis was that certain solvents 
may be able to extract non-polar lipids from the paper and leave others behind, or vice versa; 
and that a different combination of filter paper and extraction solvent might offer different 
results and therefore possibly achieve selective elution of FFA.  
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4.4.2 Materials and methods  
Lipid standard mixture D that contained TG, FFA, CE and PL was used for the first part 
of the experiment. The second part of experiment was conducted under the same principle but 
was performed at a later date and the lipid mixture used contained TG, FFA, DG and PL 
(lipid mixture C in table 4.1).  
The steps in the experiments were the same but different collection papers were used 
(903 paper for part 1 and SG paper for part 2). Twenty microliters of the lipid mixture were 
collected on each paper disc, which were dried and transferred to 20ml (903 paper) or 6ml 
scintillation vial (SG paper). Solvents tested for elution efficiency included ethanol, methanol, 
isopropanol, petroleum spirit and heptane, and methyl-tert-butyl ether (MTBE). The testing 
solvents were added to the scintillation vials containing the paper discs, 2ml for 903 paper or 
1ml for SG paper, where the paper discs were left soaking in the solvent for ten minutes. The 
resulting solvents were then extracted into another set of scintillation vials and this step was 
repeated once more. A total of 4ml (or 2ml) elution solvents was obtained, which was then 
dried under a steady nitrogen flow. The lipid extract was then transmethylated in 1% 
sulphuric acid in methanol at 70℃ for three hours and the FAME obtained were analysed on 
GC-FID.  All analyses were undertaken in triplicates.  
4.4.3 Result and discussion 
The distribution of the lipids in each compartment was calculated based on the peak 
area using the following formula: 
% 𝑜𝑓 𝑙𝑖𝑝𝑖𝑑𝑠 𝑒𝑙𝑢𝑡𝑒𝑑
=  
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑒𝑙𝑢𝑡𝑒𝑑 𝑖𝑛 𝑡ℎ𝑒 𝑠𝑜𝑙𝑣𝑒𝑛𝑡
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑖𝑛 𝑡ℎ𝑒 𝑠𝑜𝑙𝑣𝑒𝑛𝑡 + 𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑙𝑒𝑓𝑡 𝑜𝑛 𝑡ℎ𝑒 𝑠𝑝𝑜𝑡
∗ 100 
Table 4.4.1. Distribution of lipids (%) collected on 903 paper present in different 
compartments after two washes with various solvents. 
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Solvent Compartment TG 13:0 FFA 14:0 PL 22:1 CE 17:0 
Ethanol Solvent  99±0.1 98.4±3 94.3±0.2 98.4±0.2 
Paper discs 1±0.1 1.7±2.9 5.7±0.2 1.6±02 
Methanol Solvent  98.7±0.1 100 96.4±-0.3 86.1±1.4 
Paper discs 1.3±0.1 - 3.6±0.3 13.9±1.4 
Isopropanol Solvent  97.4±0.8 98.3±2.9 57.8±7.1 97±1.2 
Paper discs 2.6±0.8 1.7±2.9 42.4±7.1 3±1.2 
Petroleum 
Spirit 
Solvent 98.1±0.1 77.2±1 - 97.6±0.2 
Paper discs 1.9±0.1 22.8±1 100 2.4±0.2 
Heptane Solvent  97.9±1.6 79.3±1 - 97.9±0.3 
Paper discs 2.1±1.6 20.7±1 100 2.1±0.3 
Note: TG: triglycerides; FFA: free fatty acids; PL: phospholipids; CE: cholesterol ester. 
Table 4.4.2. Distribution of lipids (%) collected on SG paper present in different 
compartments after two washes with various solvents. 




































MTBE Solvent  96.1 
±0.4 





Paper discs 3.9 
±0.4 




















































Note: TG: triglycerides; DG: diglyceride; FFA: free fatty acids; PL: phospholipids; MTBE: 
methyl-tert-butyl ether 
There were some discrepancies regarding the methodologies used in these experiments 
as they were conducted quite some time apart. One of the most obvious differences between 
the two parts of experiment was the lipid mixture used. Part one of the experiment in this 
section was one of the earliest experiments I conducted, and at the time I considered it was 
only essential for the lipid mixture to contain the four major lipids present in human breast 
milk, that is, TG, FFA, PL and CE. I have later learned that the by-product of TG degradation 
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(DG) could potentially be another major source of contamination for FFA, which was then 
added to the lipid mixture used in later experiments, including part two in this section. In 
addition, there were more than one TG and FFA standards included in the lipid mixture for 
part two, as it was suspected that the elution efficiency may also differ due to the length of the 
carbon chain and the saturation of fatty acids, therefore I used two TG (C 13:0 and C 22:6) 
and FFA (C14:0 and C 20:0) standards with different chain lengths to cover the two ends of 
the spectrum. Second, the volume of solvent used for elution was reduced from 2ml (part 1) to 
1ml (part 2), which was partly due to change in the size of the scintillation vial used (20ml vs. 
6ml), and also the 903 paper is approximately twice thicker than the SG paper. Finally, 
different solvents were used, where methanol and isopropanol were replaced with MTBE in 
part two. Alcohols generally perform relatively similarly in these conditions, therefore only 
one was tested for the ability of elution at later time with SG paper.  
Although data were not presented, the numbers of washes required were tested, 
including one, two, three and four times. It was shown that two washes were sufficient to 
extract all possible lipids, and additional washes beyond two washes did not provide any 
further extraction.  
The elution efficiency of all three alcohols tested was relatively similar for TG and FFA 
in the 903 paper system (Table 4.4.1), where only a small percentage (or none) of lipids 
remain bound to the collection paper after two rounds of elution. Less polar solvents like 
petroleum spirit and heptane had a better elution efficiency with TG (>98%) as compared to 
with FFA (<80%) (Table 4.4.1). However, there was no tested solvents that could separate TG 
from FFA purely based on polarity. It is also noted that these less polar solvents cannot 
possibly wash off PL, the most polar lipids in breast milk, from the collection paper (Table 
4.4.1).  
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Since there were no major differences between the alcohols tested in previous 
experiment, ethanol seemingly had the best elution efficiency for all lipids as compared to 
methanol and isopropanol and was therefore chosen in the second experiment. It was noted 
that the elution efficiency was affected by the chain length of fatty acids as 96% of FFA 
C12:0 compared with 90% of FFA C20:0 had been eluted (Table 4.4.2). MTBE was brought 
into the test as my lab group was developing a new method for lipid extraction and was 
hunting for less harmful solvents to replace chloroform that is often used. It was observed that 
MTBE was capable of eluting off lipids while leaving PL bound to the SG paper (Table 
4.4.2). Compared with the results shown in Table 4.4.1, heptane and petroleum spirit 
performed worse in terms of eluting all lipids tested where majority of these lipids remain 
bound to the SG paper. This is likely due to the silica gel impregnated layer of the SG paper 
that offered additional binding strength, less polar solvent would not be able to extract the 
lipids from such a system.  
Overall, regardless of the collection paper used, none of the tested solvents were able to 
separate TG from FFA, these two lipids were often eluted off the collection paper together.  
4.4.4 Conclusion 
The separation of FFA from TG based on polarity of solvents was unsuccessful as TG 
and FFA tended to remain bound to the paper or being eluted into the solvent at a similar rate. 
The highlight from this experiment was that the combination of MTBE plus SG collection 
paper was able to retain PL while releasing all other lipids from the paper, this offers great 
potential for future studies that would like to selectively determine the concentration of PL in 
any given biological fluids; further tests would be required to refine this.  
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4.5 Separating FFA with solid phase extraction column material  
4.5.1 Rationale 
Conventional methods for lipids separation are mostly based on their polarity. Solid 
phase extraction (SPE, Ruiz-Gutierrez et al. 2000), is an alternative to TLC method and based 
on a similar principle. With a different combination of column material and extraction 
solvent, the lipids are either retained in the column or washed through the column at a 
different rate.  
 
Figure 4.5.1. Principle of solid phase extraction. 
SPE has several advantages over TLC: 1) fewer steps, and therefore less labour work; 2) 
does not involve fluorescence and ultraviolet light for visualisation of lipid separation; and 3) 
is less wasteful of solvents. However, the SPE method might be less practical than the TLC 
method, as the column has to maintain a certain level of moisture to prevent dry out, which 
could lead to poor performance of separation. The SPE method for breast milk lipid 
separation shares a common disadvantage with TLC, which is the contamination of TG due to 
its dominance in milk fats. The idea of this experiment was to use a column material of SPE 
in a powdered form rather than a cartridge. Instead of performing the separation in a SPE 
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system, the column material can be added into a scintillation vial where extracted lipids have 
been collected. The extracted lipids simultaneously bound to the binding material. It was 
hypothesised that the separation of lipid classes can be achieved by two steps of extraction, 
where the less polar neutral lipids (CE, TG and DG) can be extracted with chloroform, and 
the FFA can then be extracted with an acidified solvent or a more polar solvent (but not polar 
enough to extract PL), and leaving the PL bound to the column material.  
4.5.2 Materials and methods  
Lipid standard mixture C (containing TG, FFA, PL, DG and CE) listed in Table 4.1 was 
used to test the effectiveness of the system. 
Twenty microliters of lipid mixture were added into a 6ml scintillation vial followed by 
the addition of 500 µL of chloroform and 0.1g amino propyl powder, which was then 
vortexed for 10 seconds. After the phase separation, the upper layer was extracted and 
transferred to another 6ml scintillation vial. This process was repeated once further with 
chloroform and then repeated another time but with 2% acetic acid in diethyl ether. The 
resulting solvent from each elution was dried under a steady nitrogen flow, and the lipids 
extract was transmethylated with 1% sulphuric in methanol for three hours at 70℃, and the 
FAME formed was analysed on GC-FID. Results were based on a single sample. 
4.5.3 Result and discussion 
Table 4.5.1. Peak area of the mixed lipid standard in different washes (wash 1&2 with 
chloroform, wash 3 with 2% acetic acid in diethyl ether). 
Compartment FFA 
12:0 
TG 13:0 CE 17:0 DG 18:1 FFA 
20:0 
PL 22:1 TG 22:6 
Wash 1 - 54.7 11.6 30.1 - - 64.2 
Wash 2 - 32 6.7 18.6 - - 36.7 
Wash 3 20.8 10.8 2.2 7 28.3 - - 
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This was only a pilot run and the results were not presented as proportion of lipids in 
each wash (%) since the lipids that remained bound to the amino propyl were not measured, 
results were simply presented as peak area.  
Ideally, all neutral lipids (except the most polar PL) should be released from the amino 
propyl within the first two washes with chloroform, and the third wash of acidified diethyl 
ether was used to separate FFA from PL. Based on the peak area, the majority of TG 
(regardless of chain length), CE and DG were extracted with the first two washes of 
chloroform, where FFA and PL remained bound to amino propyl (Table 4.5.1). However, in 
the third wash with acidified diethyl ether, not only FFA, but also TG that had not been 
released from previous elution was washed off (Table 4.5.1). If assuming all TG had been 
released from the amino propyl after the third wash, this is roughly equivalent to 10% 
contamination from TG. SPE method could be seen as TLC method in a different display and 
this contamination might represent the tailing of TG on TLC plate. Further exploration could 
be made by increasing the number of washes to get rid of the effect of TG tailing; however, it 
is less likely this method would have much potential considering the difficulties and 
contaminations of separation experienced in this pilot trial.  
4.5.4 Conclusion 
This simple adopted SPE method resulted in approximately 10% contamination of TG 
during separation, and therefore failed for the purpose of developing a separation method of 
FFA that is not interfered by TG.  
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4.6 Separating FFA by binding FFA to filter paper 
4.6.1 Rationale 
From a basic chemistry point of view, a FFA molecule, when disassociated, is a cation 
that carries negative charge, which theoretically should be able to bind to collection paper that 
is treated with alkaline solution or positively charged ions. The hypothesis was that once FFA 
is bound to the paper with either basic or anion molecules, separation of FFA from other 
esterified lipids can be achieved using an extracting solvent described in section 4.4. The 
remaining FFA can be eluted with further extraction using acidified extracting solvent and 
methylated in acid-catalysed condition for identification on gas chromatography. A similar 
idea was proposed by Hornstein [Hornstein et al. 1960] and further improved by Needs 
[Needs et al. 1983], where FFA were bound to a basic anion-charged resin column and 
allowed other fats to be eluted through the column to achieve separation. 
4.6.2 Materials and methods 
Lipid standard mixture C described in Table 4.1 (containing TG, FFA, CE, PL, and DG) 
was used to establish and define the optimal pH of the collection paper, and the concentration 
of acidified acetone for further elution of FFA.  
1) Define the optimal pH of the collection paper 
Calcium chloride (CaCl2) was prepared at a concentration of 1M, the pH of which was 
approximately 6.5. The same calcium chloride was then mixed with sodium hydroxide (0.1M) 
in 1:1 ratio to obtain a solution with pH 10. Sodium bicarbonate (NaHCO3 0.5M, pH 8.5), 
sodium carbonate (Na2CO3 0.5M pH 11) was mixed at a ratio of 1:1, 2:1 and 5:1, the pH of 
such mixed solution was 10.5, 10 and 9.5 respectively. The collection paper was then treated 
by spotting 50µL of each solution, which were left at room temperature for 1 hour before use.  
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Twenty microliters of the lipid mixture were collected on the alkaline treated SG paper, 
which was dried and then transferred into 6ml scintillation vials, 1ml of acetone was added 
and the paper discs were left soaking in the solvent for ten minutes. The resulting solvent was 
transferred to another 6ml vial, this step was repeated one more time and a total of 2ml of 
solvent was collected and dried under nitrogen flow. The lipid extract was then 
transmethylated in 2ml 1% sulphuric acid in methanol at 70℃ for three hours, and resulting 
FAME was extracted with heptane and analysed on GC-FID. All samples were conducted in 
triplicate. 
2) Define the concentration of acidified solvent for FFA extraction 
To extract the FFA that were bound to the alkaline treated SG paper, the following tests 
were conducted. Twenty microliters of lipid mixture were collected on alkaline treated paper 
discs (5:1 sodium bicarbonate: sodium carbonate, 0.5M each) as described above. The lipids 
extraction step was conducted as described above. The paper discs were transferred to a set of 
6ml scintillation vials followed by acetone washes for two times to collect the neutral lipids. 
Following the neutral lipids extraction, 1ml of the acidified acetone (acetic acid in acetone, 
1%, 5% and 10%, v/v) was added to the 6ml vial, where the paper discs were left soaking in 
for 10 minutes before transferring the resulting solvents to another set of 6ml scintillation 
vial. This step was repeated once more to extract all FFA. The acidified acetone containing 
extracted FFA was dried, and 2ml of 1% sulphuric acid in methanol was then added to the 
vial for transmethylation at 70 for three hours. Resulting FAME was extracted and analysed 
on GC the same way described above.  
To further confirm that this system works even when the FFA concentration of EBM is 
abnormally high, I prepared another two sets of standards, named high FFA and high TG lipid 
mixture, representing an abnormally high proportion of FFA (60%) and a relatively low 
proportion of FFA (20%). Twenty microliters of lipid mixture were collected on the same 
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alkaline paper discs used above with a pH of 9.5. The paper discs were transferred to a 6ml 
scintillation vial for lipid extraction as described above. Two acetone washes (1ml each time) 
were used to extract neutral lipids including TG (and degraded products MG and DG) as well 
as CE. Further two acidified acetone wash (0.01%, 0.1% and 1%) were used to separate FFA 
from PL. The resulting acetone and acidified acetone containing extracted lipids were dried 
and transmethylated in 1% sulphuric acid in methanol for three hours at 70℃.  
3) Reconstitution of FFA after extraction 
Breast milk (20µL) was collected on SG paper discs treated with NaHCO3 and Na2CO3 
(0.5M each, 5:1 ratio), air-dried for 3 hours prior to analysis. The paper discs were transferred 
to 6ml scintillation vial, where lipids were extracted with two 1ml washes of acetone and two 
1ml washes of 1% acetic acid in acetone. The acidified acetone was then dried under a steady 
nitrogen flow, and the eluted FFA was re-solubilised with 600µL of heptane, or acetone, or 
50µL water and 600µL of heptane. The underivatized FFA was then analysed on the GC-FID 
with a polyethylene glycol column. 
To determine the sensitivity and precision of the system for measuring the concentration 
of FFA in EBM, a series of mixed breast milk samples with different concentration of FFA 
was prepared. A single breast milk sample was left at room temperature to deliberately 
increase the FFA concentration (aged breast milk), which was then mixed with another 
freshly thawed breast milk sample (fresh breast milk). The proportion of the aged breast milk 
accounted for 0, 25, 50, 75 and 100% of the mixed breast milk sample. These breast milk 
samples were collected on the alkaline treated SG paper discs, and the FFA was extracted as 
described above with acidified acetone after removal of neutral lipids with acetone. The 
extracted FFA was then re-solubilised in 50µL water and 600µL of heptane and analysed with 
GC-FID for underivatized FFA. Results were based on triplicates.  
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4) Stability of breast milk collected as dried spot on alkaline treated collection paper 
A frozen breast milk sample from a single milk donor was thawed for this part of the 
experiment. The thawed breast milk was either left not treated (raw) or heated treated (holder 
pasteurised or boiled). As described above, twenty microliters of breast milk were collected 
on plain SG paper (without alkaline coating), or pre-treated SG paper discs (pH 9.5), or on 
plain SG paper discs treated with alkaline solution at the time of analysis (post-treated). 
Baseline analysis was carried out three hours post sample collection after the paper discs had 
been dried completely and the rest of DMS samples were packed in a cellophane bag and kept 
at room temperature till analysis at day seven post collection. The analysis method was the 
same as described above, using acetone and acidified acetone to separate neutral lipids and 
FFA, which were then transmethylated into FAME for analysis on GC (neutral lipids) or 
injected into GC straight away for underivatized FFA analysis.  
5) Stability of TG standard collected on alkaline treated collection paper  
A mixture of triglyceride standards (C13:0 and C22:6 n-3) was collected on SG papers 
treated with solutions of varying levels of pH, ranging from 7 to 11. Plain SG paper without 
any coating was macerated in water, the pH of which was approximately 7 as measured by 
several pH testing papers (Riedel-de Haen pH 1~11; Whatman-BDH pH 8~10; Whatman-
BDH pH 6~8) for cross validation. Solutions with different pH was prepared by diluting an 
original stock solution of Na2CO3 (1M) with a pH of 11.  
The stability test was conducted similar to the method described above. Paper discs 
were left air dried for three hours after collecting twenty microliters of the TG mix. Baseline 
analysis was conducted immediately after the paper discs had been dried and the rest of 
samples were packed in cellophane bags and stored at room temperature for day 7 and 12 post 
collection analysis. At the time of analysis, the samples underwent the same elution process 
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(firstly acetone then acidified acetone) as described above, the resulting solvents were dried 
under nitrogen and extracted lipids were transmethylated in 1% sulphuric acid in methanol. 
The FAME formed was analysed by GC-FID. The acetone wash contained TG that remained 
intact and the acidified acetone contained TG that had been degraded into FFA due to 
hydrolysis. All results were based on triplicates. 
4.6.3 Results and discussion 
Results were calculated based on the peak area of individual lipids in different 
compartments. 
% 𝑜𝑓 𝑙𝑖𝑝𝑖𝑑𝑠 𝑒𝑙𝑢𝑡𝑒𝑑
=  
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑒𝑙𝑢𝑡𝑒𝑑 𝑖𝑛 𝑡ℎ𝑒 𝑠𝑜𝑙𝑣𝑒𝑛𝑡
𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑖𝑛 𝑡ℎ𝑒 𝑠𝑜𝑙𝑣𝑒𝑛𝑡 + 𝑃𝐴 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑙𝑒𝑓𝑡 𝑜𝑛 𝑡ℎ𝑒 𝑠𝑝𝑜𝑡
∗ 100 
1) Define the optimal pH of the collection paper 
Table 4.6.1. Distribution of lipids eluted into the solvent and left on silica gel paper treated 
with various solutions (% of lipids). 
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Results are based on triplicates except for calcium chloride. 
There was no binding property related to CaCl2 treated paper (Table 4.6.1), however 
whether this was due to a slight acidic pH value of the solution (approximately 6.5 due to the 
water used to prepare the solution) or the binding force between calcium ion and the FFA 
were not strong enough needed to be further investigated. I then continued to explore the 
potential binding property offered by positively charged calcium ion, but to mix it with 
alkaline solution to adjust its pH level. It was shown that the binding effect observed was 
dependent on the pH of the SG paper but had little to do with the calcium ions. A range of 
different pH was therefore tested to determine the optimal level of pH that achieve a binding 
effect.  
It was apparent that the binding effect observed was independent of the calcium ion, or 
the hydroxyl group, but dependent on the pH level. There was very little difference between 
the binding effects across different levels of pH. The 5:1 NaHCO3 and Na2CO3 solution with 
pH of 9.5 retained FFA equally as well as other solutions with higher pH, and retained the 
least level of TG than the pH 8.5 NaHCO3 solution, and therefore was chosen to be the final 
pH of the paper. However, an increased pH level of the paper could lead to chemical 
hydrolysis of the TG itself, therefore the lowest possible pH was the preferred option.  
2) Define the concentration of acidified solvent for FFA extraction 
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After all neutral lipids being washed off the filter paper, I was then set to look for a 
solvent to further extract the FFA that bound to the alkaline filter paper. After elution of 
neutral lipids, there were only FFA and PL left on the filter paper, the goal was to extract FFA 
only without contamination from PL, therefore a mild acid, acetic acid was chosen for this 
part of experiment.  
Table 4.6.2. Exploring the optimal concentration of acid in acetone for extracting FFA from 
alkaline treated SG paper.  
















Paper discs 0.6 0 0 1.5 0 99.2 0 
Acetone wash*2 2.2 98.8 100 95.9 1 0 98.4 
H+/acetone 
wash*2 
97.2 1.2 0 2.6 99 0.8 1.6 
5% 
H+/acetone 
Paper discs 0 0 0 1.2 0 84 0 
Acetone wash*2 2 98.6 100 96.1 0.7 0 97.9 
H+/acetone 
wash*2 
98 1.4 0 2.7 99.3 16 2.1 
10% 
H+/acetone 
Paper discs 0 0 0 1.1 0 64.9 0 
Acetone wash*2 2.2 98.2 100 96.8 1.5 0 98.8 
H+/acetone 
wash*2 
97.8 1.8 0 2.1 98.5 35.1 1.2 
Note: the pH of the filter paper was 9.5. Acidified acetone was prepared with acetic acid in 
acetone (v/v). Results are based on a single sample. 
There was no difference between the three different concentrations of acidified acetone 
used in terms of the ability to elute FFA from the alkaline filter paper (>97%). However, the 
proportion of PL being washed off the filter paper increased with increasing the acidity of the 
acetone solvent, which defeated the purpose of purifying the FFA by leaving PL bound to the 
paper. It seems that 1% would be considered the highest possible concentration of acid in 
acetone for extracting FFA from the alkaline treated paper; further exploration around 
lowering the acid content of acetone was then needed.  
In my previous research conducted during my honours degree, I have observed that the 
FFA concentration of aged breast milk (collected between 2012-12, stored at -80℃ until 
analysis in 2016) could be as high as 30% to 40% of breast milk fats. As a result, for this next 
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part of experiment, I specifically prepared a lipid mixture containing 60% FFA to simulates 
this abnormal fat composition. 
Table 4.6.3. Extraction efficiency of lipids (% of total lipids) spotted on silica gel paper with 































































































































































































































Note: The pH of the filter paper was 9.5. Acidified acetone was prepared with acetic acid in 
acetone (v/v). Results are based on triplicates.  
It was revealed that 1% acidified acetone is considered the optimal concentration to 
release FFA from the alkaline collection paper, in both high FFA lipid mixture and the high TG 
lipid mixture (Table 4.6.3). Lowering the acid concentration of acetone weakened its ability to 
elute FFA from the collection paper (Table 4.6.3). The loss of a small percentage of FFA in the 
acetone wash and left on the paper discs occurred but can be corrected with addition of an 
internal standard, and therefore is not a major concern. 
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3) Reconstitution of FFA after extraction 
After lipid class separation using the method described above, all TG (and its degraded 
product DG and MG) and CE were collected in the first two acetone washes while FFA was 
collected in the latter acidified acetone wash and PL was still bound to the collection paper. The 
plan was that all neutral lipids should then undergo the standard transmethylation process, from 
which I can calculate the amount of these neutral lipids with an internal standard. Then the 
underivatized FFA collected in the acidified acetone wash would then be dried, reconstituted 
and injected straight into a polyethylene glycol column designed specifically for separation and 
identification of FFA. This experiment was therefore conducted to determine the best way to 
reconstitute FFA after lipid extraction and separation. 
 
Figure 3.6.1. Re-solubilisation of free fatty acid with various solvent after being eluted from 
pre-treated silica gel paper (pH of 9.5) with acidified acetone (1% acetic acid in acetone, v/v). 
It was observed that the peak area of total FFA recorded was the highest for those re-
solublised in water plus a heptane system, rather than in heptane or acetone alone (Figure 3.6.1), 
however this number did not reveal whether or not all FFA had been counted. In this experiment 




















Different solvent or solvent combination
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other more polar solvents are likely to create back flush in the system and lead to contaminations 
between samples and possible damage to the column itself. It was suspected that the FFA eluted 
from the SG paper was protonated (due to the acidified acetone) and therefore could not be re-
solubilised simply into a solvent. The protonated FFA molecules must be neutralised in ordered 
to be re-solubilised properly. Water is the preferred option over an alkaline solution that might 
in turn combine with FFA to create salt and therefore precipitate FFA and defeat the purpose 
of re-solubilisation. In addition, the idea of reconstitute FFA with water and heptane was 
inspired by our routine practice in the laboratory, where FAME derived from all lipids were 
extracted with water and heptane after transmethylation. The ratio between water and heptane 
is important, as increases in the volume of water would result in an increased volume of 
emulsified layer between heptane and water, This would not only lead to difficulties with 
heptane extraction, but also may trap some FFA in the emulsion layer and result in incomplete 
extraction. It was determined that the best ratio between water and heptane was 1:12, which 
was 50µL of water with 600µL of heptane that gives almost no emulsion layer and a relatively 
clear separation between the two layers.  
It was observed that reconstituted FFA with water and heptane resulted in the highest 
total peak area when compared with the reconstituted FFA with heptane or acetone alone. 
However, there was no confirmation that all FFA had been reconstituted. In order to address 
this concern, I then undertook a series of EBM samples containing varying concentration of 
FFA to test the feasibility of this system.  
 




Figure 4.6.2. Relationship between the proportion of aged breast milk (v/v, %) in the sample 
and the free fatty acid peak area measured by GC-FID with polyethylene glycol column.  
 
There was an almost linear relationship between the total FFA peak area of breast milk 
and the proportion of aged breast milk in the sample. It revealed that this system was precise 
enough to identify the difference in the concentration of FFA between different milk samples. 
However, this was still not adequate to answer the question of whether all FFA had been 
reconstituted.  
Given all the data presented above, I believed that this system was a functioning system 
for separating and identifying FFA, however, there were two major concerns to be examined 
before being used further. The first was a test of the stability of the system at room 
temperature, and the second was to measure the accuracy of this system by lipid standards and 
cross validation with another method.  





















Proportion of high FFA (aged) breast milk in the sample
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While I continued to work on investigating how to determine whether all FFA was 
reconstituted after elution, I proceeded to tackle the next problem, the stability of DMS at 
room temperature. Before attempting this experiment, I had simply collected some human 
milk samples as dried spot and left it at room temperature and -20℃ freezer for two weeks to 
monitor the changes to its FFA concentration. To my surprise, the FFA concentration of 
samples stored at room temperature, but not in freezer, was elevated significantly. This was 
observed in both samples collected on alkaline treated paper with pH of 9.5, also samples 
collected on plain SG paper (as a control/reference). It was suspected that the hydrolysis of 
TG in human milk was due to the high pH of the paper which resulted in chemical 
breakdown. It was also possible that there was bacterial contamination of this donated milk 
sample which caused biological breakdown of TG. Cold storage in both cases could have 
supressed the rate of hydrolysis and therefore such elevation of FFA concentration was not 
seen in samples stored at -20℃ freezer. This was tested repeatedly, and I found that the most 
apparent changes to the FFA concentration of DMS occurred within the first week of storage 
in any testing condition, which seemed reached a plateau thereafter. Hence, in order to save 
time and speed up the progress, a 7-day storage period at room temperature was considered 
sufficient for determining whether there were any changes occur to the fat composition of 
human milk.  
To assess whether the increase in FFA concentration of samples collected as DMS was 
due to chemical hydrolysis or bacterial contamination, the following experiment was planned. 
Three types of human milk (raw, holder pasteurised and boiled milk) was prepared from a 
single donor milk, any potential bacterial contamination could be destroyed by boiling or 
holder pasteurisation. These three types of milk were collected on SG paper that were plain 
(not coated with alkaline solution), coated with alkaline solution prior to collection or after 
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storage but prior to analysis. It was hoped that this combination of filter paper and different 
milk samples could reveal the source of TG breakdown.  
 
 
Figure 4.6.3. Changes to the free fatty acid concentration of raw, holder pasteurised and 
boiled breast milk collected on a. pre-treated alkaline paper with pH 9.5, or b. post-treated 
alkaline paper with pH 9.5, or c. on plain filter paper at baseline and 7 days after storage at 
room temperature. HP: holder pasteurised.  
 
The concentration of FFA in raw breast milk collected on plain SG paper doubled after 
7 days of storage at room temperature. In contrast, that of holder pasteurised milk and boiled 
milk increased slightly and remained unchanged, respectively. For milk samples collected on 
pre-treated SG paper, the FFA concentration of all breast milk, regardless of whether it was 
raw, holder pasteurised or boiled, all increased between baseline and 7 days but to a different 
extent. Notably, the FFA concentration in raw and holder pasteurised milk was slightly higher 
than the concentration in boiled milk at 7 days. An elevated concentration of FFA was 
observed in raw and pasteurised breast milk collected on post-treated alkaline paper, but not 
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in boiled milk collected on the same collection paper. There were two likely reasons for 
degradation of TG and hence an increase in the FFA concentration observed at 7 days. On 
plain SG paper, there was no chemical exposure, therefore, any changes to the FFA 
concentration of breast milk collected are likely due to biological breakdown as a result of 
lipase activity (raw milk) or bacterial contamination. Holder pasteurisation and boiling 
reduced or eliminated the potential sources of biological breakdown seen in raw milk, resulted 
in small or no increases in the FFA concentration. Whereas, the FFA concentration of boiled 
milk collected on pre-treated filter paper, which supposedly inactivates all lipases and 
eliminated all bacteria, also increased from 1.5 mg/ml to 2.8mg/ml, which was likely a result 
of chemical breakdown due to pH of the paper. No change was observed in the FFA 
concentration of boiled milk collected on post-treated alkaline paper, which might indicate 
that the chemical breakdown only happens when the sample has been stored for prolonged 
periods. Increasing in the FFA concentration of all types of milk collected on post-treated SG 
paper was likely due to biological breakdown of TG.  
It was suspected that the pH of the paper was too high and hence resulted in chemical 
breakdown of TG. Therefore, the pH of the paper was further lowered to 8.5 which is the 
minimum level that achieves binding effect of FFA. However, in term of stability test, FFA 
concentration in boiled breast milk collected on SG paper with pH of 8.5 was increased 
significantly at 7-day post collection. Therefore, the stability of a mix of TG standard 
collected on SG paper varying in pH value was conducted at room temperature to determine 
whether the pH was responsible for breakdown of TG. 
5) Stability of TG standard collected on alkaline treated collection paper  
In previous section I explained how I discovered there was a ‘window of most apparent 
changes’ to human milk FFA concentration, which happened within the first seven days of 
collection. This part of experiment of stability of pure TG standards collected as dried spot at 
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room temperature went along before that discovery and was originally set for a 14-day storage. 
However, upon realising that changes should have occurred within the first seven days, I 
decided to terminate this stability test earlier than its due date, which resulted in a 12-day 
storage period at room temperature.  
% 𝑇𝐺 𝑏𝑒𝑖𝑛𝑔 𝑙𝑖𝑏𝑒𝑟𝑎𝑡𝑒𝑑
=  
𝑃𝑒𝑎𝑘 𝑎𝑟𝑒𝑎 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑓𝑜𝑟𝑚𝑒𝑑 𝑖𝑛 𝑡ℎ𝑒 𝑎𝑐𝑖𝑑𝑖𝑓𝑖𝑒𝑑 𝑎𝑐𝑒𝑡𝑜𝑛𝑒 𝑤𝑎𝑠ℎ
𝑃𝑒𝑎𝑘 𝑎𝑟𝑒𝑎 𝑜𝑓 𝐹𝐴𝑀𝐸 𝑓𝑜𝑟𝑚𝑒𝑑 𝑖𝑛 𝑡ℎ𝑒 𝑎𝑐𝑒𝑡𝑜𝑛𝑒 𝑤𝑎𝑠ℎ + 𝑖𝑛 𝑎𝑐𝑖𝑑𝑖𝑓𝑖𝑒𝑑 𝑎𝑐𝑒𝑡𝑜𝑛𝑒 𝑤𝑎𝑠ℎ
∗ 100 
 
Figure 4.6.4. Percentage of triglyceride mix standard (C17:0 and C22:6, 5mg/ml each) 
collected on SG paper with various pH level being liberated during storage at room 
temperature for 12 days.  
 
It was found that, using a mixed TG standard (C17:0 and C22:6 n-3, both in 5mg/ml), 
detection of FFA varied according to the pH level of the filter paper at the end of a 12-day 
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may be correlated with the pH of the paper. The release of FFA on the filter paper that had a 
neutral pH level could have been due to spontaneous hydrolysis at room temperature rather than 
due to the effect of pH.  
4.6.4 Conclusion 
This method was very close to success as it gets rid of the tailing of TG by binding FFA 
to the paper and therefore selective elution of TG was achieved; GC equipped with the 
polyethylene glycol column further purified the results as only FFA can be recognised by the 
machine. However, the chemically treated paper itself hydrolysed TG and resulted in instability 
of the milk fats collected on such paper which cannot be stabilised at room temperature for long 
periods of time. In addition, it was found that breast milk itself when collected as dried spot is 
still susceptible to TG breakdown due to the presence of milk lipases and possibly bacterial 
contamination. The final working system was further developed based on data gathered from 
these experiments, and by addressing unresolved questions regarding whether all FFA were 
resolubilised or can be resolubilised, and the optimal way to denature breast milk lipases or 
eliminate bacteria. This will be discussed in the next chapter.  
Discussion and conclusion  
To summarise the three essential characteristics of to support widespread use of this 
proposed filter paper-based method for measuring the free fatty acid concentration of human 
milk are: 1) requires a small volume of sample; 2) provides an accurate FFA measurement that 
is not contaminated by TG and 3) is stable at room temperature. 
All the experiments described in this chapter were tested repeatedly, however for brevity, 
only results from a single set of experiment are presented. The majority of the methods 
described in this chapter failed to separate FFA from TG without contamination, except the 
very last method described in 4.6, which involved binding the FFA with alkaline treated filter 
paper and analysed on a polyethylene glycol column that only recognised underivatized FFA 
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and was not interrupted by the TG fraction. Therefore, only the method described in 4.6 
progressed to stability testing. The use of polyethylene glycol column cannot be applied in any 
other methods described in section 4.1-4.5 because the FFA were methylated into FAME. 
Method described in section 4.4 eventually evolved into the successful method that will be 
described in the next chapter. 
For most of the experiments presented in this chapter, the peak area was used as the 
parameter for various calculations (e.g. for the completion of transmethylation or elution), with 
the exception of the stability test of method 4.6, where an internal standard was used. Using 
peak area for calculation was the best measurement at the time to test the feasibility of each 
method. Nevertheless, it is acknowledged there were very small variations in peak area arising 
due to the instrument itself. Internal standards would have been a better option, however, most 
of the methods described in this chapter failed in the early stage of feasibility testing. Because 
of this and the need to run many trials for each method tested, the use of the peak area of 
individual lipids was a convenient and appropriate choice, that was sufficient for the purpose.  
At the beginning, only 903 paper was used as the collection tool because it is the most 
used filter paper for collection in the field for inborn error screening in newborns. There have 
been several reports of using SG paper in dried blood or milk spot technique for the 
measurement of long chain polyunsaturated fatty acids [Gao et al. 2019; Liu et al. 2014;] and 
its metabolic product oxylipins [Hewawasam et al. 2019]. The silica gel coating of the filter 
paper offered additional binding strength with the polar lipid, PL in human milk. At the early 
stage of my research, PL was not considered the major source of contamination and therefore 
the use of SG seemed unnecessary. However, in later experiments, it was discovered that the 
SG paper used in combination with acetone as an elution solvent is capable of trapping PL and 
further purify the lipid extracts obtained from the DMS. SG paper was therefore the preferred 
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collection assay used in section 4.6. It was also later found that this combination resulted in the 
highest recovery rate of FFA from the DMS, which will be discussed in the next chapter.  
From the stability tests conducted in the FFA binding method in 4.6, it was clear that 
there were two different possible reasons behind the TG breakdown, the chemical hydrolysis 
due to high pH of the filter paper and the lipolysis caused by bacteria and/or lipases. Chemical 
hydrolysis was associated with the alkaline coating (the fundamental component of this FFA 
binding method), which could have caused chemical breakdown of the TG collected on paper 
due to its high pH level. It is also possible that the milk was bacterially contaminated and hence 
the breakdown of TG could have been due to bacteria. Alternatively, the lipases that are present 
in breast milk were not stabilised by the fact that the collection of milk in a DMS format and 
may have still actively broke down TG. I looked further into investigating the source of TG 
degradation and potential means to prevent it, which will be discussed in the next chapter.  
In conclusion, there were a number of challenges in developing this micro-sampling DMS 
system, notably, contamination by TG fats and the instability of milk fats caused by either 
bacterial contamination or endogenous lipases. All the unsuccessful methodologies described 
in this chapter ultimately shaped the final DMS system that will be described in Chapter 5. It 
is important to note that though methods recorded in this chapter failed to separate FFA from 
other lipids of breast milk without contamination from TG, these separation methods remain 
possible for other biological fluids where trace contamination from TG is negligible.
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Chapter 5 A simple system for measuring the level of free fatty acid 
in human milk collected as dried milk spot 
 
 
It has been repeatedly shown in the previous chapter that there were two major challenges 
involved in developing a dried milk spot method for measuring the FFA concentration of 
breast milk. These were 1) eliminate the contamination from TG for an accurate FFA 
measurement and 2) identify and eliminate the causes of lipolysis (likely due to lipases) to 
preserve the fat composition. Therefore, this chapter will describe how these two major issues 
were tackled and lead to a successful sensitive and precise DMS method, specifically for 
determining the FFA concentration of human milk, even at a tiny volume. This method has 
achieved long term stability even at room temperature by denaturing the lipases in human 
milk.  
 
This chapter includes a manuscript in its published form: 
Gao, C., Liu, G., McPhee, A.J., Miller, J., Gibson, R.A. (2020). A simple system for 
measuring the level of free fatty acids in human milk collected as dried milk spot. 
Prostaglandins, Leukotrienes and Essential Fatty acids, 158: 102035. 
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Chapter 6 Free fatty acid concentration of expressed breast milk 
used in neonatal nursery 
 
Elevated FFA concentration has been associated with prolonged storage and handling 
process due to the presence of lipases in human milk. However, there is lack of data on the 
endogenous concentration of FFA in human milk prior to any storage and handling to define 
the magnitude of changes that may have occurred, primarily due to lack of suitable technique. 
With the dried milk spot method described in previous chapter, I was able to collect a wide 
range of samples from the neonatal units of one of the local hospital to describe the common 
levels and variations of FFA in human milk that were freshly expressed and collected at cot 
side, and that of human milk collected at home and brought into the unit for use.   
 
(The study logo used in the neonatal units)  
This chapter includes a manuscript in its published form: 
Gao, C., Miller, J., McPhee, A.J., Rumbold, A., Gibson, R.A. (2020). Free fatty acid 
concentration in expressed breast milk used in neonatal intensive care units. Breastfeeding 
medicine, 15:11.  
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Chapter 7 General discussion 
 
With the expansion of human milk banking in Australia and globally, there is a need to 
develop a simple and robust system for assessing the stability of human milk fats during 
collection, processing, storage, and distribution. Understanding the magnitude of changes that 
may occur to milk fats during this journey is one critical step to safeguard the nutrition of 
vulnerable preterm infants. The most notable change likely to occur to breast milk fat 
composition during storage and/or handling processes is the liberation of FFA from the main 
fat type in breast milk, TG (Chapter 2). Because there was no modern accurate tool for its 
measurement, the investigations I conducted during my candidature were directed towards 
developing a dried milk spot (DMS) system to accurately and precisely determine the fat 
composition of human milk (Chapter 3 for total fatty acid composition, Chapter 4 and 5 for 
FFA concentration). Collecting human milk as a DMS reduces the volume of samples 
required for analysis, eliminates the needs for cold-chain storage and transportation, and 
bypasses the liquid-liquid extraction step and allows direct measurements of the fat 
composition. Following development of a stable method, the clinical applicability and 
sensitivity of the DMS method was tested using freshly collected human milk samples from 
one local hospital (Chapter 6).  
This is the first report of a DMS method for measuring the FFA concentration in human 
milk, which also stabilises the fat composition at room temperature for a minimum of eight 
weeks. Conventional TLC-GC methods for measuring the FFA concentration of human milk 
are time-consuming, requires lipid extraction and purification prior to separation and 
esterification. Some are also prone to falsely FFA measurement due to contamination from 
the TG fraction (due to tailing of TG on TLC plate). Even though there have been previous 
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reports of selective esterification of FFA by first adsorbing it with an anion pre-treated resin 
filled column [Hornstein et al. 1960; Needs et al. 1983], separation of FFA from other lipids 
required several rounds of elution with various solvents. Such a method is solvent-wasteful 
and time-consuming and could potentially result in uneven recovery of fatty acids, which 
limits its applicability in practice. In contrast, collecting human milk as a dried spot bypasses 
the extraction and purification step that is required in many conventional methods for FFA 
analysis. The final system described in Chapter 5 used a special polyethylene glycol column 
in the gas chromatograph that allows the separation of underivatized FFA even in presence of 
other esterified lipids, such as TG. Using this DMS system eliminates the needs for 
esterification, improves the accuracy of measurement and further simplifies the analytical 
process.   
The successful development of the DMS for FFA measurement did not come without 
setbacks. The major challenge that I faced was due to the unique lipid composition of human 
milk. Unlike other biological fluids (e.g. plasma), human milk fats are overwhelmingly 
dominated by one type of fat, TG (>98%). Although it would be deemed unimportant and 
negligible in research of other bodily fluids, any trace contamination from TG is not 
acceptable for the analysis of human milk fats. Although I was able to reduce the 
contamination from TG to approximately 2% in some of the methods I have attempted 
(Chapter 4), I was still not satisfied as even a 1% contamination from TG could mean a 50% 
apparent increase in FFA and therefore a falsely high FFA reading. To my surprise, it was 
found that lipases of human milk remained active even when collected in the form of dried 
spot (Chapter 4 and 5). Identifying a method to effectively inactive these lipases that would 
not interrupt the fatty acid composition of human milk, and would be suitable in a range of 
clinical and other settings was the next problem to tackle. The two commonly used methods, 
conventional oven heating and protein precipitation generated inconsistent results and/or did 
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not completely stop the lipase from breaking down TG and liberating FFA during storage. 
The only effective tool to denature lipases to achieve long term stability at room temperature 
was microwaving at high power for three minutes (Chapter 5).  
The usefulness of the DMS method for FFA measurement was demonstrated via a small 
clinical project (Chapter 6). In a three-month study, I collected over 250 expressed human 
milk samples from 32 mothers with an infant or infants admitted to the neonatal unit at the 
Women’s and Children’s Hospital. A recent report revealed that the main barrier for human 
milk collection in neonatal units is low milk supply by the mothers, followed by discharge 
prior to collection and staff unavailability [Galante et al. 2019]. The fact that I was able to 
collect hundreds of samples within a relatively short period mostly on my own, was largely 
due to the utility of the DMS technique. It required only a minute amount of sample, was easy 
to manage in practice and was well accepted by the participants. This study was also one of 
the few studies that were able to measure the endogenous FFA concentration of human milk 
prior to any storage and handling [Bitman et al. 1983; Chappell et al. 1985]. The other studies 
achieved this by immediately adding lipase inhibitor or organic solvent following milk 
collection, however, this is not feasible to be undertaken outside of a laboratory (e.g. in a 
neonatal nursery) due to safety concerns. In contrast, the use of a microwave for deactivating 
lipases in the DMS system is safe and more practical for clinical settings.  
This thesis would have been more complete with one more component, to determine the 
effect of fortification on the fat composition of human milk during storage and feeding. 
Fortification with human milk fortifiers (containing hydrolysed bovine or human milk protein 
and minerals) is one last preparation step prior to the delivery of expressed milk to infants that 
are born with a birth weight less than 1800 grams. To the best of my knowledge, there has 
only been three previous studies to examine the effects of fortification [Donovan et al. 2017; 
Jocson et al. 1997; Schlotterer et al. 2019].  
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While conducting research in the neonatal unit, I have observed that there were some 
notable differences between fortified mother’s own milk (MOM) and fortified pasteurised 
donor human milk (PDHM), in term of smell, colour and consistency. In our local neonatal 
unit, fortified human milk (both MOM and PDHM) is prepared once every 24 hours and 
loaded into several syringes (one syringe per feed), which are kept in a refrigerator until use. 
Each feeding lasts two hours at room temperature, therefore the longest storage duration that 
any feed may be exposed to is 24 hours in the refrigerator plus two hours at room 
temperature. Further research is needed to investigate how fortification affects the stability of 
fats in human milk during storage and over time, and whether addition of human milk fortifier 
would further accelerate the rate of FFA liberation compared to non-fortified milk. Other 
research questions to be addressed include whether there are any differences between MOM 
and PDHM in terms of the degree of FFA liberation, and the variations in concentration of 
FFA in fortified human milk at its end-of-life (after feeding has been completed), which 
represents the actual human milk infants may receive (detailed experimental plan see 
Appendix 2.).  
One other interesting observation was that the FFA concentration of DMS rapidly 
increased during the first seven days after collection at room temperature, which then reached 
a plateau. During this process, the FFA concentration increased to approximately 5~7mg/ml, 
which is equivalent to 16~23% of total fats, assuming a fat content of 30mg/ml (Chapter 4 
and 5). A similar pattern of change in FFA concentration in liquid human milk was also 
observed in some other smaller experiments I have conducted, where a plateau was seen after 
24 hours storage at room temperature and 48 hours in the refrigerator, respectively 
(unpublished data). Whether this was due to a lack of substrate or that the activity of lipases 
naturally decayed over time was not further investigated. However, in some other human milk 
samples I measured during my Honours degree, the FFA concentration of human milk after 
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prolonged storage at -80℃ (collected at 2012-13 and analysed in 2016), had reached 30~40% 
of total fat. It may suggest that the number of lipases may have been reduced but their activity 
remained. However, it is noted that not all TG were converted to FFA even after prolonged 
storage. It was also found that the FFA composition changed with storage time, with an 
increase in the proportion of total n-6 polyunsaturates and correspondent reduction of total 
saturates and total n-3 polyunsaturates (unpublished data). Whether the liberation of FFA is 
related to the position of the fatty acid on the glycerol backbone [Qi et al.] needs further 
investigation.  
Researchers have delved into studying the total fat content and fatty acid composition 
(pooled from both esterified and non-esterified lipids) of human milk but have paid very little 
attention to the FFA of human milk (e.g. its role and function, and determinants of its 
concentration in human milk). This is surprising considering the first step of fat digestion is to 
liberate fatty acids from their esterified structure, to then be freely circulated and readily 
absorbed. FFA, without being bound to a pre-existing esterified structure, are considered the 
primary source of usage, the role of which in infant health needs to be further explored. 
Previous research with preterm infants has shown that intestinal fat absorption may be 
impaired as a result of pasteurisation of human milk when compared with raw milk 
[Andersson et al. 2007]. This is likely due to the absence of lipases and to a lesser extent 
lipolysis during cold storage, leading to a lower concentration of FFA [Vincent et al. 2020]. 
However, this has received limited attention in the research literature. Future studies are 
required to clarify the consequences of FFA in human milk for health and developmental 
outcomes (fat absorption, growth, incidence of NEC etc.). This includes observational studies 
to define the relationship between FFA and clinical outcomes, and the ultimately clinical trials 
that examine whether deliberately increasing the FFA concentration of human milk (e.g. 
through repeated freeze and thaw or prolonged storage) would be favourable for infants’ 
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growth and development. A DMS method that is reliable and requires only a small amount of 
sample for analysis provides the optimal tool to monitor FFA in future studies.  
In the current DMS system I developed, accurate quantification of FFA relies on precise 
control of the volume of milk collected on the paper. At the time of analysis, a single 
underivatized odd chain fatty acid at a known concentration (internal standard) is added into 
the DMS sample as the standard reference to calculate the total amount of FFA in the milk 
sample. This could be improved by using an endogenous component of human milk that 
occurs at a constant concentration as the standard instead (e.g. lactose). Without having to add 
the standard manually, this endogenous standard could be extracted along with the fat of milk 
and injected into a high performance liquid chromatography (HPLC) or liquid 
chromatography mass spectrometry (LCMS) machine for separation and quantification. Using 
such a parameter as standard, collecting human milk at an exact volume would no longer be 
required for this DMS method. This is a more practical option as it allows the participants to 
be directly involved and engaged in the collection procedure, collecting milk themselves and 
faster milk collection, which would enable multiple samples to be collected per day. This 
should be a priority for future research, as it would enable more accurate examination of the 
maternal factors and diurnal factors that may affect the FFA concentration of human milk. 
The development of new advanced technologies in lipidomic analysis has seen the 
discovery of oxylipins, the metabolic products of FFA, which are smaller molecules that are 
thought to mediate the biological effects of fatty acids. Although the role of oxylipins in 
human health is still being clarified, previous research has shown that blood FFA and oxylipin 
profile [Suganuma et al. 2020] can influence the growth trajectory of preterm infants during 
hospital stay [Alexandre-Gouabau et al. 2018], irrespective of whether the lipid source is 
human milk or parenteral nutrition. Whether this relationship occurs for long term growth 
remains to be investigated.  
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Not only does the fat composition of human milk change after handling and storage 
(Chapter 2), recent reports also suggest that the oxylipins of human milk are also thermal 
sensitive, being affected by both pasteurisation [Pitino et al. 2019] and storage conditions 
[Wu et al. 2016]. Although oxylipins were not the focus of this thesis, a fellow student had 
developed a method for determining the oxylipins in blood collected as a dried spot 
[Hewawasam et al. 2019]. There is great potential to further extend the applicability of my 
DMS method to include oxylipin analysis. One potential improvement is to use a hole punch 
rather than the whole DMS paper disc for analysis, which would mean it is possible to 
measure both FFA and oxylipins from a single collection. This final system is likely to be of 
great interest to human milk banks, as it could be adopted as a simple quality assurance step 
to measure the integrity of milk pre- and post-pasteurisation. 
Further research is warranted to understand the optimal techniques to safely process 
donor human milk. The current gold standard, the holder pasteurisation method, though with 
proven abilities to eliminate transmissible viruses that may be present in donor milk, also 
destroys the valuable components of human milk that are thermally sensitive. We have seen 
many attempts made by scientists to develop non-thermal technologies (e.g. high pressure 
processing [Delgado et al. 2014; Molto-Pugmarti et al. 2011; Pitino et al. 2019] and ultra-
violet radiation [Christen et al. 2013; Pitino et al. 2019]) for pasteurising human milk in the 
hope that these techniques preserve the pivotal components of breast milk. None have so far 
been introduced to human milk processing on an industrial scale. There needs to be a 
continuous effort in searching for alternative non-thermal technologies to replace holder 
pasteurisation. This could not happen without a reliable and practical tool to identify changes 
in the thermal sensitive components of breast milk from different processing techniques. A 
DMS method with minimal usage of human milk is the perfect tool to undertake this. Another 
fruitful area for further research is to explore the feasibility of using DMS as a tool for 
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measuring other nutritive components of human milk such as oligosaccharides, as well as 
chemical contaminants such as phthalates [Main et al. 2005]. The process of which would 
require machines such as HPLC and LCMS, but the extraction and analysis could all be 
completed in one 96-well plate setting. 
In addition to the huge potential applicability of DMS to human milk banking, as well 
as the dairy and oil industry, where FFA concentration is often an indicator of rancidity of the 
products. This dried spot technique could be extended to determine the level of FFA in other 
biological fluids, such as plasma and serum. Serum and plasma FFA concentration have been 
associated with a range of adult chronic disease including metabolic dysfunction (obesity and 
type-2 diabetes [Schrieks et al. 2018; Steffen et al. 2015]) coronary artery disease [Jin et al. 
2019; Pilz et al. 2006; Schrieks et al. 2018] and hypertension [Tabara et al. 2014]). However, 
the exact role of FFA in the increased risk of these diseases is unclear, including the relative 
importance of the total concentration of FFA versus specific FFA types. The current standard 
method for measuring FFA concentration in serum and plasma in clinical settings is limited to 
enzymatic assays, which only provides quantitative data (e.g. the amount) but not qualitative 
data about the types of fatty acid. Addition, there is concern that the results may only be valid 
within a narrow range of FFA concentration [Song et al. 2019]. As such, the current FFA 
detection methods in serum and plasma are not reliable enough to be used as a screening to 
assess disease risk. The DMS method described in this thesis has huge potential to be adapted 
to serum and plasma FFA measurement. This would provide a cheaper alternative tool that is 
highly accurate and precise, which provides both quantitative and qualitative results for 
screening potentially clinical diagnosis and prognosis of chronic disease. This is an exciting 
area for future research.  
In conclusion, I have developed a micro-sampling method for measuring the fat 
composition of human milk collected as dried spot, which is stabilised by microwaving, and 
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can be stored at room temperature for a minimum of eight weeks without deteriorating. In a 
small clinical project conducted in the neonatal nursery, I demonstrated that the DMS method 
is easy to manage and well accepted by the breastfeeding mothers due to that small amount of 
sample that is required. This is the first report of a reliable and accurate DMS method for 
detecting changes in human milk fat composition that could be suitable for implementation 
not only large scale clinical studies, but also the human milk banking industry for monitoring 
the quality of donor human milk throughout the processing 
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Supplementary material for the systematic review included in Chapter 2 
Additional records for the systematic review 
Since the publication of the systematic review in May 2019, there have been eight new 
studies published, and two were missed out during the initial search for the published 
manuscript, the characteristics of these studies are detailed in Table 2.1 and the results are 
shown in Table 2.2.  
Six [Adhisivam et al. 2019; Chang et al. 2020; Kim et al. 2019; Orbach et al. 2019; 
Paulaviciene et al. 2020; Tanriverdi et al. 2019] of the ten additional studies reported changes 
to the total fat content of human milk after various storage and handling procedures, while 
only one study [Wesolowska et al. 2019] determined its effect on the total fatty acid 
composition. Three [Chappell et al. 1984; Hung et al. 2018; Wesolowska et al. 2019] of the 
included studies measured the changes to free fatty acid concentration/proportion, and one 
[Capriati et al. 2019] reported for triglyceride concentration/proportion.  
Overall, results from the additional records captured are in line with the observation and 
conclusion of the published systematic review. The total fat content and total fatty acid 
composition of human milk is less likely affected by different storage and handling process, 
where changes were seen in term of total fat content, it was likely due to poor sample 
processing technique and may also be due to methodological errors. For instance, the total fat 
content of human milk samples measured after various treatment varied significantly in Kim 
et al. 2019 (e.g. 21% increase after microwave heating while 20% reduction after storage), 
and this is likely due to a poor homogenisation of samples prior to analysis.  
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Similar to the findings of the published systematic review, changes to the fat 
composition (lipid classes), the concentration or proportion of triglycerides and free fatty 
acids were observed after various storage and handling processes. Capriati and colleagues 
[Capriati et al. 2019] reported approximately 20% reduction in triglyceride concentration after 
holder pasteurisation (HP) or modified HP, the results are in agreement with previous 
observation, which fit in with our hypothesis that the lipases remained functioning during the 
time frame where temperature was gradually increased and result in further lipolysis. 
However, Welsolowska et al. determined the effect of HP and high-pressure processing on 
the free fatty acid concentrating of human milk using a conventional titration method and 
concluded that both method resulted in reduction in FFA concentration, for up to 50%. For 
the effect of storage, the concentration of FFA in human milk continuously to rise, following 
a time-dependent manner, in both room temperature and domestic freezer storage setting 
[Chappell et al. 1984; Hung et al. 2018]. Whereas, no changes to the FFA concentration was 
observed if the samples were stored in deep freezer [Chappell et al. 1984]. Although the data 
were not formally reported, Chappell et al. also reported that the FFA concentration of human 
milk was further increased after two rounds of freeze-thaw cycle, but not any more after the 
third cycle.  
In conclusion, current storage and handling practices of human milk is less likely to 
affect its total fat and total fatty acid composition, unlike the fat composition (or lipid 
classes), which is altered by storage, pasteurisation and repeated freeze and thaw cycles.  
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Kim et al 
(2019, 
Korea) 
N/S Mature  N/S N/S N/S - RT, fridge and 
frozen storage  
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fat content (g/dL) 
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Paulavicin
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fat content (g/dL) 
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Tanriverdi 







N/S N/S - Frozen storage  43 donors Human milk analyser – total 
fat content (g/dL) 
Positive 
Weslowsk



















Titration – free fatty acid 
concentration (reported as % 
loss as compared to control) 
GC: FA composition 
Neutral 
Abbreviations: HP: holder pasteurisation; HHP: high pressure processing; NS: non-specified; TG: triglycerides; FA: fatty acids; FFA: free fatty 
acid; GC: gas chromatography; FID: flame ionization detector; RT: room temperature; HPLC: high performance liquid chromatography. 
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Table 2.2. Effect of different intervention on the fat composition of breast milk as published 
in the additional records  
Component  Intervention Effect 
Total fat  Room temperature storage  
 • 1 week Reduction (20.6%) 
[Kim 2019] 
 Refrigerator storage  
 • 1 week No statistically 
significant change  
[Kim 2019] 
 Domestic freezer storage  
 • 1 week Reduction (11.6%) 
[Kim 2019] 
 • 1 month Reduction (14.2%) 
[Kim 2019] 
 • 2 months Reduction (11.3%) 
[Kim 2019] 




[Orbach 2019]  
 Deep freezer storage  
 • Up to 6 months No statistically 
significant change 
[Orbach 2019] 
 Holder Pasteurisation No statistically 
significant change 
[Paulaviciene 2020] 
Reduction (up to 25%) 
[Adhisivam 2019; Chang 
2020] 
 Thawing   
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 • RT Reduction (12.2%) 
[Kim 2019] 
 • Bottle warmer Reduction (11.6%) 
[Kim 2019] 
 • Microwave  No statistically 
significant change  
[Kim 2019] 
 Warming  
 • Microwave Increase (24.1%)  
[Kim 2019] 
Total fatty acid 
composition 
Holder pasteurisation No statistically 
significant change 
[Wesolowska 2019] 





Holder pasteurisation Reduction (18.3%) 
[Capriati 2019] 
 Modified Holder pasteurisation Reduction (21.1%) 
[Capriati 2019] 
Free fatty acid 
concentration/proportion  
Domestic freezer storage  
 • 1 week Increase (78%)  
[Hung 2018] 
 • 1 month Increase (250%) [Hung 
2018] 
 • Unspecified timeframe Increase (585%) 
[Chappell 1984] 
 Deep freezer storage  
 • Unspecified timeframe No statistically 
significant change 
[Chappell 1984] 
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 Holder pasteurisation Reduction (50.2%) 
[Wesolowska 2019] 




References for these additional records: 
Adhisivam, B., Vishnu Bhat, B., Rao, J., Kingsley, S.M., Plakkal, N., Palanivel, C. (2019). Effect 
of holder pasteurisation on macronutrients and immunoglobin profile of pooled donor human 
milk. Journal of maternal, fetal and neonatal medicine, 32: 3016-3019. 
Capriati, T., Goffredo, B.M., Argentieri, M., De Vivo, L., Bernaschi, P., Cairoli, S., Laureti, F., 
Reposi, M.P., Marino, D., Benedetti, S., Diamanti, A. (2019). A modified holder pasteurisation 
method for donor human milk: preliminary data. Nutrients, 11:1139. 
Chang, F.Y., Fang, L.J., Chang, C.S., Wu, T-Z. (2020). The effect of processing donor milk on 
its nutrient and energy content. Breastfeeding Medicine, 15: 576-582. 
Chappell, J.E., Clandinin, M.T., McVey, M.A., Chance, G.W. (1984). Free fatty acid content of 
human milk: physiological significance and artifactual determinants. Lipids, 20: 216-221. 
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Supplemental Table 1. The PRISMA checklist  
 




TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data 
sources; study eligibility criteria, participants, and interventions; study appraisal and 
synthesis methods; results; limitations; conclusions and implications of key findings; 
systematic review registration number.  
3 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  4 
Objectives  4 Provide an explicit statement of questions being addressed with reference to 
participants, interventions, comparisons, outcomes, and study design (PICOS).  
5 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web 
address), and, if available, provide registration information including registration 
number.  
5 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used as criteria 
for eligibility, giving rationale.  
5-6 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with 
study authors to identify additional studies) in the search and date last searched.  
5 
Search  8 Present full electronic search strategy for at least one database, including any limits 
used, such that it could be repeated.  
5 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in 
systematic review, and, if applicable, included in the meta-analysis).  
6 
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Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, 
in duplicate) and any processes for obtaining and confirming data from investigators.  
6 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding 
sources) and any assumptions and simplifications made.  
 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies (including 
specification of whether this was done at the study or outcome level), and how this 
information is to be used in any data synthesis.  
6 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).   
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, 
including measures of consistency (e.g., I2) for each meta-analysis.  
6 
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., 
publication bias, selective reporting within studies).  
5-6 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-
regression), if done, indicating which were pre-specified.  
6 
RESULTS  
   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, 
with reasons for exclusions at each stage, ideally with a flow diagram.  
7 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, 
PICOS, follow-up period) and provide the citations.  
7 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome level 
assessment (see item 12).  
7 
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple 
summary data for each intervention group (b) effect estimates and confidence 
intervals, ideally with a forest plot.  
Table 1 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and 
measures of consistency.  
7-13 
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Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).  7 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, 
meta-regression [see Item 16]).  
Table 2-3 
DISCUSSION  
   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main 
outcome; consider their relevance to key groups (e.g., healthcare providers, users, and 
policy makers).  
13-14 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level 
(e.g., incomplete retrieval of identified research, reporting bias).  
13 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and 
implications for future research.  
14-15 
FUNDING  
   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply 
of data); role of funders for the systematic review.  
15 
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Supplementary Table 2. Search strategies used for individual database  
Datab
ase 
Search strategies  
PubM
ed 
((((((Human breast milk[tw] OR Human milk[tw] OR Milk, human[mh] OR Milk 
bank[tw] OR Milk banks[mh]  
OR Breastfeeding[mh]))) AND (Food preservation[mh] OR Preservation, 
biological/methods[mh] OR Food  
storage[mh] OR Food storage/methods[mh] OR Time factors[mh] OR 
Refrigeration[mh] OR Freezing[mh]  
OR Freezing/adverse effects[mh] OR Refrigeration/adverse effects[mh] OR 
Temperature[mh] OR Cold  
temperature[mh] OR Hot temperature[mh] OR Hot temperature/adverse 
effects[mh] OR Heating/adverse  
effects[mh] OR Microwaves[mh] OR Microwaves/adverse effects[mh] OR 
Pasteurization[mh] OR  
Pasteurization/methods[mh] OR Sterilization[mh] OR Thawing[tw] OR Thaw[tw] 
OR Freeze/thaw[tw] OR  
Fortifier[tw] OR Milk fortification[tw] OR Enteral nutrition/adverse effects[mh] 
OR Enteral nutrition[mh]  
OR Food handling[mh] OR Food handling/methods[mh])) AND (Milk, 
Human/analysis[mh] OR Fats/analysis[mh]  
OR Fatty acids[tw] OR Fatty acids[mh] OR Fatty acids/analysis[mh] OR Fatty 
acids, Nonesterified/analysis[mh]  
OR Lipids[tw] OR Lipids[mh] OR Lipids/analysis[mh] OR Lipolysis[tw] OR 
Lipolysis[mh] OR Dietary fat[tw]  
OR Dietary fats[mh] OR Dietary fats/analysis[mh] OR Triglycerides/analysis[mh] 
OR Hydrolysis[mh] OR  
Diglycerides/analysis[mh] OR Docosahexaenoic acid/analysis[mh] OR Linoleic 
acid/analysis[mh] OR Linolenic  
acid/analysis[mh] OR Arachidonic acid/analysis[mh]))) NOT ((animal[mh] NOT 
human[mh])) AND (Humans[Mesh]  
AND English[lang] AND Female[MeSH Terms]) 
Emba
se 
(('breast milk':de,ti,ab OR 'milk bank':de,ti,ab) AND ('food handling':exp OR 'food 
storage':exp OR 'storage  
temperature':exp OR 'low temperature':exp OR 'refrigeration':de,ti,ab OR 'food 
freezing':exp OR 'cryopreservation':exp 
OR 'pasteurization':de,ti,ab OR 'high temperature':exp OR 'instrument 
sterilization':exp OR 'temperature dependence':exp  
OR 'heating':de,ti,ab OR 'thawing':de,ti,ab OR 'freeze thawing':de,ti,ab OR 'time 
factor':exp OR 'food irradiation':exp OR 'microwave irradiation':de,ti,ab OR 'milk 
fortification':de,ti,ab OR 'enteric feeding':exp) AND ('lipid':de,ti,ab OR 'lipid 
analysis':exp OR 'lipolysis':exp OR 'lipid hydrolysis':exp OR 'fatty acid':de,ti,ab 
OR 'fatty acid analysis':exp OR  
'triglycerol':exp OR 'diglycerol':exp OR 'monoglycerol':exp OR 'arachidonic 
acid':exp OR 'linoleic acid':exp OR  
'docosahexaenoic acid':exp)) NOT [medline]/lim 





( TITLE-ABS-KEY ( "human breast milk" )  AND  TITLE-ABS-KEY ( "Storage 
temperature"  OR  "refrigeration"  OR  "pasteurization"  OR  "freezing"  OR  
"sterilization"  OR  "heating"  OR   
"thawing"  OR  "freeze-thaw"  OR  "microwave"  OR  "milk-
fortification"  OR  "enteral nutrition"  OR  "enteral feeding" )  AND  TITLE-
ABS-KEY ( "lipid"  OR  "fatty acid"  OR  "lipolysis"  OR  "free fatty 
acid"  OR  "lipid hydrolysis" ) )  AND NOT  INDEX ( medline )  
 
  




Flow diagram of the planned experiment regarding fortification of human 
milk mentioned in Chapter 7 
 
Figure 7.1. Flow diagram of planned in vitro experiment. Black text represents the 
steps or procedures, red highlights the sampling points and green represents the research 
questions to be answered. MOM: mothers’ own milk. PDHM: pasteurised donor human milk.  
 
 
